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Neuronal and glial glutamate transporters function to clear synaptically released glutamate from 
the extracellular space. This process not only ensures the spatial and temporal fidelity of 
excitatory signaling, but also prevents neuronal death triggered by excess glutamate. In addition, 
glutamate transporters possess a substrate-gated anion channel function, which may play an 
important role in shaping synaptic transmission.  Although much progress has been made on the 
topology, structure, and function of these carriers, our knowledge of the conformational 
dynamics that drive glutamate transporter functions is far from complete.  
Using biochemical, electrophysiological and functional assays in combination with 
computational simulations, we identified several large-scale collective motions that are intrinsic 
to glutamate transporter trimers. These collective motions are functionally important for 
substrate transport, but not for the substrate-gated anion conductance. Furthermore, we showed 
that these collective motions are coupled to the inward movement of the transport domain, and 
thus serve a critical function in the transport cycle. Next, we identified a conserved arginine 
residue, R388 in human EAAT1, that is involved in both substrate transport and anion 
conduction. Mutants reversing the positive charge (R388D and R388E) predominantly exist in 
the anion leak state and abolish the substrate-activated anion current. We also demonstrated that 
the transport domain in the negatively-charged mutant R388D spends a longer time in the 
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inward-facing orientation in the absence of substrate compared to the wild type transporter. 
These results not only suggest the characterized arginine residue is an important element in the 
functional coupling between substrate transport and the anion channel activity, but also indicate 
the role of the inward transport domain movement in anion permeation. Finally, we constructed a 
functional glutamate transporter concatemer. Our preliminary results suggested that glutamate 
transporters are functional as trimers and the individual subunits transport substrate 
independently. 
The work presented in this dissertation provides a greater understanding of the structural 
determinants of the dual functions of glutamate transporters. Furthermore, it provides a powerful 
tool to further study contributions of subunit interactions and the inward piston-like movement of 
the transport domain to channel gating and anion permeation.  
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1.0  INTRODUCTION 
 
1.1 GLUTAMATE TRANSPORTERS AND EXCITATORY SYNAPTIC 
TRANSMISSION 
The amino acid L-glutamate is the major excitatory neurotransmitter in the mammalian central 
nervous system. It is released from presynaptic neurons in response to electrical impulses (e.g. 
action potentials). Within less than a millisecond, glutamate diffuses across the synaptic cleft and 
transmits information to postsynaptic neurons by acting on both synaptic and extrasynaptic 
glutamate receptors. The glutamate concentration in the extracellular environment determines the 
extent and duration of receptor activation and thus glutamate clearance plays an essential role in 
the maintenance of precise communication between neurons. In addition, excessive activation of 
glutamate receptors is neurotoxic and the rapid clearance of glutamate limits the neuronal death 
that can be caused by high extracellular glutamate concentrations (1).  
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1.1.1 Extracellular glutamate is mainly removed by glutamate transporters and reused in 
the cell 
Unlike the neurotransmitter acetylcholine, glutamate is not inactivated by specific extracellular 
enzymes. Although simple diffusion plays an important role in reducing glutamate 
concentrations in the synaptic cleft at a submillisecond timescale, the maintenance of low 
extracellular glutamate concentrations relies on the active uptake into cells by glutamate 
transporters (2). These carriers transport L-glutamate, L-aspartate and D-aspartate with high 
affinity (Km in low micromolar range). Once it enters the neuronal cytoplasm, glutamate can be 
used subsequently for protein synthesis in cellular metabolism, or packaged in vesicles for re-
release during neurotransmission. By contrast, glutamate transported into glial cells is initially 
converted to glutamine by glutamine synthetase. Glutamine is then actively transported back 
from glial cells into presynaptic neurons to serve as a source for new glutamate synthesis. This 
trafficking of glutamate and glutamine between neurons and glial cells is referred to as the 
glutamine-glutamate cycle, and has been proposed to be a major pathway by which glutamate is 
recycled (3).    
1.1.2 Glutamate transporters and diseases 
As the major excitatory signaling molecule, glutamate contributes to nearly all aspects of normal 
brain development and function. Altered clearance of glutamate as a consequence of glutamate 
transporter malfunction is associated with a variety of neurological diseases and psychiatric 
disorders (4). Sustained elevation of extracellular glutamate, either due to the downreglutation of 
transporter activity or by glutamate release through a direct reversal of the transporter, leads to 
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severe excitotoxic damage to surrounding neurons. This mechanism is implicated in both acute 
brain injuries (e.g. epilepsy and ischemia), and chronic pathological conditions, including 
amyotrophic lateral sclerosis, Huntington’s disease and Alzheimer’s disease (4). On the other 
hand, glutamate hypoactivity, which could result from the upregulation of transporter functions, 
has been reported to occur in schizophrenia patients (1, 4). Glutamate transporters thus represent 
potential therapeutic targets for treating these neuropsychiatric and neurodegenerative diseases, 
and understanding the structural determinants of transporter functions will help in the design of 
allosteric transport regulators and inhibitors of reverse transport.  
1.2 FUNCTIONAL PROPERTIES OF GLUTAMATE TRANSPORTERS 
Over the last three decades, the study of the structure and function of glutamate transporters has 
spanned from initial investigations of transport system in brain slices, synaptosomes and plasma 
membrane vesicles to extensive explorations of individual transporter subtypes exogenously 
expressed in cultured cells, greatly expanding our knowledge of this protein family.  
1.2.1 Glutamate transporter subtypes  
Early studies showed that glutamate transport activities in different brain regions have distinct 
pharmacological profiles, suggesting the existence of more than one subtypes of glutamate 
transporters (5-6). This diversity was confirmed by the cloning of the first three genes encoding 
different subtypes of glutamate transporters in 1992: rat GLAST, rat GLT-1 and rabbit EAAC1 
(7-9). To date, five members of glutamate transporter family have been characterized from 
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human (10-12) and a variety of other eukaryotic species (for a review, see (13)). The human 
transporters were named using the acronym EAAT (Excitatory Amino Acid Transporter) (12). 
Based on sequence similarity, EAAT1 is homologous to GLAST, EAAT2 to GLT-1 and EAAT3 
to EAAC1. Several prokaryotic genes have also been isolated, including proton dependent 
glutamate transporters from Escherichia coli, (GltPEc), Bacillus stearothermophilus (GltTBs) and 
Bacillus caldotenax (GltTBc), as well as a dicarboxylic acid transporter from Rhizobium meliloti 
(DctA) (14-16). Other glutamate transporter family members include two related neutral amino 
acid transporters ASCT1 and ASCT2, which transport L-alanine, L-serine and L-cysteine (17-
18). The primary sequences of the five mammalian carriers share ~50% identity and ~60% 
similarity, while the identity with the prokaryotic carriers is around 20-30%. It is therefore 
reasonable to assume that the mammalian EAATs will have many structural and mechanistic 
features in common with their prokaryotic counterparts. However, considerable variations in 
structure, ion requirements and substrate selectivity exist between different subtypes, which 
sometimes makes it difficult to compare structure-function data obtained from different family 
members. 
 
1.2.2 Glutamate transport cycle  
Glutamate transporters belong to a secondary active transporter family that uses free energy 
stored in ion/solute gradients to enable the uphill translocation of their substrates. Studies in 
brain slices, synaptosomes and brain-derived cell lines revealed that glutamate transport is 
thermodynamically coupled to the inward movement of multiple sodium ions (19-20) and a 
proton ion (or an OH- is ejected) (21), and to the outward movement of a potassium ion (22). The 
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detailed coupling stoichiometry has been further explored using the cloned human EAAT1 
expressed in Xenopus oocytes (23), as well as GLT-1 expressed in CHO cells (24). It is now 
generally accepted that for mammalian carriers the transport cycle involves two sequential half-
cycles (Figure 1A): i) co-transport of 1 glutamate with 3 sodium ions and 1 proton ion into the 
cell cytosol, and ii) counter-transport of 1 potassium ion to return transporters to their externally-
facing, unoccupied state. Based on the Goldman-Hodgkin-Katz equation and physiological ion 
gradients, such stoichiometry enables the generation of  up to a 106-fold gradient of glutamate 
across the cell membrane, which could bring the extracellular glutamate concentration down to 
approximately 10 nM (23).  Glutamate transport is therefore electrogenic, as two net positive 
charges move into the cell with each transport cycle. The resulting current is referred to as 
transport current, and is sometimes termed coupled transport current or uptake current because it 
represents the stoichiometric charge movements associated with glutamate transport. 
1.2.3 Transporter associated anion conductance  
Glutamate transporters also function as anion channels (Figure 1B). Before the cloning of 
glutamate transporters, Attwell’s group observed a glutamate-activated chloride conductance in 
retina photoreceptors (25). These currents displayed properties in common with glutamate 
transporters: they were Na+-dependent, and could be inhibited by transporter inhibitors. Several 
groups made similar observations (26-27), but the direct association of an anion current with a 
glutamate transporter remained unclear until the identification and characterization of a human 
EAAT4 (11). Application of glutamate to Xenopus oocytes expressing recombinant EAAT4 
generates a current that is predominantly due to chloride ions and is not blocked by compounds 
that inhibit endogenous chloride channels. The chloride current through the transporter is 
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thermodynamically uncoupled from the substrate transport process because the rate of uptake is 
independent of the presence of Cl- or the direction of Cl- flux (11). Subsequent studies of other 
transporter subtypes confirmed that mammalian EAATs as well as structurally related neutral 
amino acid transporters, known as ASCTs, have intrinsic anion channel activities (10, 28-31).   
More recently, Ryan et al. used proteoliposomes to identify an uncoupled chloride conductance 
in a glutamate transporter homolog GltPh from the archaeal species Pyrococcus horikoshii, 
suggesting that chloride permeation is a feature conserved in both prokaryotic and eukaryotic 
carriers (32). In addition to the anion conductance activated by glutamate, mammalian EAATs 
also possess an anion leak conductance in the absence of substrate (33-35). The anion leak 
currents are activated by extracellular Na+ and can be blocked by transporter inhibitors. Thus, 
there are two distinct anion currents associated with EAATs, and they are referred to as the Na+-
activated anion leak current and the substrate-activated anion current. 
Although the physiological function of the Na+-activated leak chloride current associated 
with glutamate transporters is not yet clear, the substrate-activated chloride current can influence 
synaptic transmission in several ways.  First, coupled glutamate transport generates a net transfer 
of two positive charges per transport cycle. The influx of Cl- counteracts the accumulation of 
positive charges during transport, which otherwise will depolarize the cell and inhibit voltage-
dependent glutamate transport. Consistent with this idea, the rate of transport slows rapidly in 
GltPh-containing liposomes if Cl- or other permeant anions are not present in the uptake media 
(32). Second, the influx of Cl- may serve as a feedback sensor of extracellular glutamate 
concentration to dampen neuron excitability and prevent further glutamate release. This 
mechanism is elegantly demonstrated in rat rod bipolar cells which express a transporter that has 
relatively large Cl- conductance compared to the coupled transport current (36).   
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Figure 1. Transport cycle and stoichiometry of EAATs 
(A) Simplified state diagram of the EAAT transport cycle. After glutamate and coupled ions (step 1) bind to the 
transporter (T), they are translocated (step 2) and released into the cell cytosol (step 3). Next K+ binds from the 
intracellular side (step 4) and reorients the substrate-free transporter (step 5). K+ is released outside the cell (step 6). 
(B) Cartoon illustrating the ion coupling stoichiometry of an EAAT (blue). The uptake of 1 glutamate molecule is 
coupled with the influx of 3 Na+, 1 H+ and the efflux of 1 K+ (black). In addition, EAATs have a glutamate-activated 
Cl- conductance (red), which results in the influx of chloride ions under physiological conditions. 
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1.3 MOLECULAR STRUCTURES OF GLUTAMATE TRANSPORTERS 
An appreciation of the molecular structures of glutamate transporters has been a crucial first step 
towards understanding how structural elements contribute to different aspects of transporter 
function. This section will focus on the current knowledge of the general membrane topology 
and the subunit stoichiometry of glutamate transporters.   
 
1.3.1 Membrane topology of glutamate transporters  
Hydropathy analyses of GLAST-1, GLT-1 and EAAC-1, as well as direct experimental evidence 
provided support for the presence of six transmembrane (TM) α-helices in the N-terminal part of 
glutamate transporters with two N-glycosylation sites located in the extracellular loop between 
TM domain 3 & 4 (Figure 2) (37-38). However, structural predictions were ambiguous for the 
C-terminus, in part because of many charged residues present within the otherwise hydrophobic 
domains. Early studies attempted to assess the membrane orientation of a reporter epitope fused 
with sequential C-terminal deletions of glutamate transporters, resulting in several different 
models for the C-terminal domains (37, 39-40). Despite the the information gathered, these 
studies were criticized for being based on data using truncated non-functional transporters, which 
might not reflect the organization of full-length native carriers. 
 As an alternative approach, several laboratories used cysteine substitutions combined 
with thiol-modifications to determine the membrane topology of the C-terminal domains. In 
these strategies, single cysteine residues are introduced into regions of interest and their 
accessibility probed with various sulfhydryl-reactive reagents. Residues that can be modified by 
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both membrane permeable and impermeable agents are designated as extracellular, whereas 
residues that can only be modified by membrane permeant agents are intracellular. Finally, 
residues that do not react with either permeable or impermeable agents are presumed to reside 
within TM domains (41). Two models were developed for human EAAT1 (42-43) and GLT-1 
(44-45) respectively using this kind of approach, and the results for GLT-1 generally agreed with 
the predicted topology of the bacterial transporter GltTBs (46-47). Both mammalian carrier 
models (Figure 2A and 2B) proposed the existence of re-entrant loops, but differed in the 
number and location of the TM domains and re-entrant loops. The major basis for the differences 
in the two models is the accessibility of a single substituted residue, A395C in human EAAT1 
(A393C in GLT-1) (43, 45). Although A395C in human EAAT1 could be readily modified by 
small impermeant methanethiosulfonate reagents (MTSET and MTSES), implying an 
extracellular location, Kanner and colleagues showed that the corresponding residue in GLT-1, 
A393C, is inaccessible by these reagents and placed it at the end of a large intracellular loop.  
A breakthrough in understanding the membrane topology of glutamate transporters came 
with the first crystallization of the archaeal transporter GltPh [Protein data bank (PDB) ID: 
1XFH] (48). GltPh exists as a trimer comprised of three identical subunits in the crystal. Each 
protomer contains eight TM domains and two re-entrant loops. The first six TM domains form a 
scaffold surrounding a C-terminal transport domain that contains structural elements required for 
the transport mechanism. The C-terminal transport domain includes two opposite-facing helical 
hairpins (HP1 and HP2), a seventh TM helix interrupted by a β-linker and an amphipathic helix, 
TM8 (Figure 2C and 2D). A non-protein electron density nestled between HP1 and HP2 was 
also observed in the crystal and was later confirmed to be the bound substrate (49).  
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Figure 2. Structural features of GltPh and the mammalian EAATs  
Three different membrane topology models are illustrated in panels A-C. Two were suggested based on the results 
obtained in substituted cysteine modification studies using human EAAT1 (A) and GLT-1 (B), and the third (C) was 
revealed by the crystallization of an archaeal homolog from Pyrococcus horikoshii, GltPh. (D) Cartoon 
representation of the GltPh protomer viewed in the plane of the membrane. Transmembrane domains 1-6 colored in 
grey form a scaffold that holds the transport domain comprised of HP1 (yellow), TM7 (orange), HP2 (red) and TM8 
(magenta). Residue A395 in human EAAT1 referred to in the text (equivalent to A393 in GLT-1 and A307 in GltPh) 
is shown as red dots in the topology models (A-C) and is also illustrated as a blue sphere in the GltPh protomer (D). 
(E) View of a GltPh trimer parallel to the membrane. Subunits in the trimer are colored green, magenta or cyan. The 
protomer and the trimer structure are based on the GltPh crystal structure 1XFH (48), and are made using the 
software Pymol (Schrödinger, LLC). 
3 
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Therefore, this GltPh structure is referred to as the substrate-bound conformation. One striking 
feature of GltPh is that it forms a large bowl-shaped basin that extends halfway through the 
membrane and thus, several regions in the C-terminal part are solvent accessible despite their 
location within the plane of the membrane (Figure 2E). 
Although many structural features of glutamate transporters, including the existence of 
two re-entrant loops, were predicted by the substituted cysteine modification studies, the exact 
locations of the TM domains and the re-entrant loops in GltPh differ from the proposed 
mammalian models (Figure 2C). How well does the membrane topology of GltPh represent that 
of the mammalian EAATs?  
To address this question, it is useful to revisit data obtained from substituted cysteine 
modification studies in light of not only the substrate-bound GltPh structure, but also the two 
other available 3-dimensional GltPh structures. A second structure (PDB ID: 2NWW), referred to 
as the TBOA-bound conformation, was crystallized in the presence of a competitive inhibitor, 
DL-threo-benzyloxyaspartate (TBOA) (Figure 3A). The overall structural features of the 
TBOA-bound GltPh are very similar to those of the substrate-bound carrier (PDB ID: 1XFH) 
except that the HP2 region is displaced away from the substrate binding site (49). A third GltPh 
structure (PDB ID: 3KBC) was recently resolved by crosslinking two cysteines introduced into 
TM2 and HP2 (Figure 3B). This structure is referred to as the inward-facing conformation, in 
which the C-terminal transport domain moves inward approximately 18Å toward the cytoplasm 
(50).  
Each crystal structure of GltPh may represent a single snapshot of one of many 
conformational states that occur during the transport cycle, and the carrier dynamics are likely to 
affect the solvent accessibility of certain protein domains. When residues characterized in 
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substituted cysteine modification studies using mammalian carriers were mapped onto the three 
reported GltPh structures based on their sequence alignment, the thiol-modification behavior of 
many of these residues can be explained by at least one of these GltPh structures. For example, 
the residue A395C in human EAAT1 noted above is located in the vicinity of the unwound 
segment “NMDGT” in TM7 and is occluded by the HP2 region in the substrate-bound GltPh 
structure (Figure 2D). At first glance, this residue seems to be inaccessible from either the 
intracellular or extracellular side of the cell. However, the displacement of HP2 in the TBOA-
bound GltPh structure exposes this residue to the extracellular environment (Figure 3A) and the 
inward movement of the transport domain in the inward-facing GltPh structure exposes it 
intracellularly (Figure 3B). Therefore, A395C can be accessed from both sides of the cell, which 
reconciles differences in the modification of this residue observed experimentally in human 
EAAT1 and GLT-1 (43, 45). Indeed, the modification of the residue A395C by another thiol-
reactive methanethiosulfonate reagent, MTSEA, was protected by L-glutamate only when 
MTSEA was applied at low concentrations but not at high concentrations. As MTSEA can 
permeate the cell membrane under some conditions, this observation suggests that at high 
concentrations MTSEA can modify A395C from the cytoplasm and supports the idea that this 
residue is alternatively accessed from either side of the membrane (43).  
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Figure 3. Mammalian EAATs and GltPh share similar structure features 
Residue A307 shown as a blue sphere (equivalent to residue A395 in human EAAT1 and A393 in GLT-1, refer to 
the main text), is accessible from either the extracellular space in the TBOA-bound conformation (A) or the 
intracellular space in the inward-facing conformation (B). Note that TBOA in (A) is removed from the structure for 
clarity. The spatial relationships among C-terminal transmembrane domains are conserved between GltPh and 
EAATs, as shown in C and D. (C) Residue pairs in the mammalian EAATs that were characterized to form copper 
phenathroline (CuPh)-induced disulfide crosslinks when substituted with cysteines are illustrated on the GltPh 
structure. Shown in blue are two pairs identified in GLT-1, A412C/V427C (pair 1, TM7/HP2) and A364C/S440C 
(pair 2, HP1/HP2), corresponding to A326/I341 and S279/G354 in GltPh, respectively. Shown in green are two pairs 
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identified in human EAAT1, A395C/A367C (pair 3, TM7/HP1) and A395C/A440C (pair 4, TM7/HP2), 
corresponding to G280/A307 and A307/T352 in GltPh, respectively. (D) Residue pairs that are spatially close in the 
GltPh structure were confirmed by substituted cysteine crosslinking studies in the mammalian EAATs. These include 
pairs of L363/L387 (pair 5, HP2/TM8), L367/Y383 (pair 6, HP2/TM8) and I325/Y383 (pair 7, TM7/TM8) in GltPh, 
corresponding to M449C/L466C, L453C/I463, I411C/I463C in GLT-1, respectively. The illustrations are based the 
GltPh crystal structures 2NWW, 2NWX and 3KBC, and are made using the software Pymol (Schrödinger, LLC). 
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Cysteine crosslinking studies have provided even stronger evidence supporting the 
structural similarities between GltPh and the mammalian EAATs. These studies aimed to look for 
residue pairs that are close in space and when mutated to cysteines could be crosslinked by 
oxidizing reagents such as copper phenanthroline (CuPh). The rationale for the original studies 
was simply based on similarities of residue pairs in thiol accessibility and modification rate, and 
in the ability of substrates, coupled ions and non-transportable analogs to prevent or enhance 
modification. These studies identified residue pairs of A412C/V427C (TM7/HP2) and 
A364C/S440C (HP1/HP2) in GLT-1 (51), and pairs of A395C/A440C (TM7/HP2) and 
A395C/A367C (TM7/HP1) in human EAAT1 (52). When these residue pairs are mapped onto 
the substrate-bound GltPh structure, they are also sufficiently close in space to allow the 
formation of disulfide bonds when substituted with cysteines (Figure 3C). The structure of GltPh 
was also used as a model to look for additional pairs, which led to the identification of residue 
pairs of M449C/L466C (HP2/TM8), L453C/I463C (HP2/TM8), I411C/I463C (TM7/TM8) in 
GLT-1 (Figure 3D) (53). These results clearly demonstrate that the relative positions of TM7, 
TM8, HP1 and HP2 are conserved in GltPh and the mammalian EAATs. 
 
 
1.3.2 Glutamate transporters form trimers  
It has long been proposed that EAATs form multimers (54) and the quaternary stoichiometry was 
explored with various biochemical approaches, including the use of chemical crosslinking 
reagents. Early studies showed that GLT-1 migrates as a trimer in SDS polyacrylamide gels after 
crosslinking, whereas GLAST may exist as both trimers and dimers (54). Similar crosslinked 
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trimer species were observed for two bacterial transporters, GltBc and GltBs (55) and for the 
mammalian transporter EAAC1 (56). The trimeric structure was further confirmed for human 
EAAT2 and the bacterial transporter GltPEc using blue native polyacrylamide gel analysis (57).  
In addition, by applying a coupled chromatographic and spectroscopic technique that accurately 
measures the native molecular masses of membrane proteins, Yernool et al. have shown that 
GltTBc and GltTBs have molecular weights of 140 kDa and 154 kDa respectively under non-
denaturing conditions, approximately three times the size of their corresponding protomers (55). 
Although one study reported a pentameric assembly of human EAAT3 (58), with the 
crystallization of GltPh as a symmetric trimer, it is generally accepted that glutamate transporters 
are comprised of three identical subunits, and this stoichiometry appears conserved in both 
prokaryotic and eukaryotic carriers (48). In addition, recent studies demonstrated that EAAT3 
and EAAT4, but neither EAAT1 and EAAT2 nor EAAT2 and EAAT3, coassemble into stable 
heterotrimers in in vitro expression systems (59). Although the biological significance of the 
hetero-oligomerization of EAAT3 and EAAT4 is currently unknown, it has been shown that 
EAAT3 and EAAT4 are coexpressed in several cell types in the mammalian brain (60-61), 
suggesting that heterotrimers might represent a significant portion of the native transporters. 
Thus, GltPh and the mammalian EAATs form trimers and also share similar 3-
dimensional membrane topology, at least for the C-terminal part of the proteins. In addition to 
these shared features, the mammalian EAATs have a segment of more than 50 amino acids 
between TM4b and TM4c containing N-linked glycosylation sites, which is absent in GltPh. It 
has been postulated that these extra residues form a loop that extends from the center of the 
trimer basin and is accommodated in the large vestibule formed by the assembly of three 
subunits (62). Further studies are needed to reveal the membrane topology of the N-terminal part 
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of the mammalian EAATs in three dimensions, particularly the structure of the additional 
residues not present in GltPh.  
1.4 BINDING SITES FOR GLUTAMATE AND COUPLED IONS 
Structural analyses, including mutagenesis studies and crystallography, have also examined 
potential binding sites for substrates and for the various coupled ions, Na+, H+ and K+, providing 
data that have facilitated our understanding of transport mechanisms. Mutagenesis studies have 
generally focused on conserved polar or charged amino acid residues because of their potential 
for interacting with charged substrates and coupled ions. However, these studies have limitations 
because changes in substrate binding or ion dependence can arise from structural changes that 
indirectly alter the binding sites. In this section, we will consider the residues critical for the 
binding of glutamate and coupled ions, comparing results from mutagenesis studies with the 
binding sites resolved in the GltPh structures (49). 
 
1.4.1 Substrate binding site 
Elements of the substrate binding site were resolved at the atomic level for GltPh by exploiting 
the fact that L-cysteine sulphinic acid (L-CS) binds tightly to GltPh and produces a clear 
anomalous scattering from its sulfur atom (49). Because GltPh prefers L-aspartate over L-
glutamate as a substrate, the structure of L-aspartate was superimposed on the electron density of 
L-CS assuming that the γ-carboxyl group of L-aspartate occupies the same position as the 
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sulphinic acid group of L-CS. This strategy revealed a substrate binding site formed by the tips 
of HP1 and HP2, the unwound region of TM7 (NMDGT motif) and the polar residues of 
amphipathic TM8 (Figure 4A), which is very similar to the previously observed non-protein 
electron density in the substrate-bound GltPh (48). Several key interactions important for 
substrate binding were also suggested for GltPh. These include interactions between the amino 
and α-carboxyl groups of L-aspartate with R276/S278 (HP1), V355 (HP2), D394/N401 (TM8), 
as well as interactions between the γ-carboxyl group with T314 (TM7), G359 (HP2) and R397 
(TM8).  
The importance of the charged residues D394 and R397 for substrate binding is 
compatible with data obtained in the mammalian EAATs. Without any available high resolution 
structural information, these studies were based on the comparison of amino acid sequence 
variations between subtypes displaying different substrate specificities. Conradt et al. noticed 
that R479 in GLAST-1 (R397 in GltPh) is conserved in acidic amino acid transporters, but a 
threonine residue sits in the corresponding position in the neutral amino acid transporter, 
ASCT1. Mutation of the arginine in GLAST-1 to threonine abolishes glutamate uptake, 
suggesting that R479 is essential for substrate transport (63). Evidence directly linking this 
residue to glutamate binding came from a mutagenesis study of the equivalent residue in EAAC-
1, R447 (64). Wild type EAAC-1 transports L-cysteine in addition to acidic amino acids. 
Mutated carriers with uncharged or negatively-charged substitutions at R447 no longer transport 
acidic amino acids, but are still able to accumulate L-cysteine. In addition, these mutated carriers 
transport L-serine, which is not a substrate for wild type EAAC-1. Acidic amino acids do not 
compete with L-cysteine, indicating that they no longer bind to the R447 mutant carriers. Thus, it 
was proposed that R447 (EAAC-1 numbering) interacts with the γ-carboxyl group of glutamate.  
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Studies using a similar strategy identified another conserved aspartate residue D444 in 
EAAC-1 (D394 in GltPh) that is also important for the productive interaction with acidic amino 
acid substrates (65).  The bacterial dicarboxylic acid transporter DctA has a serine residue in 
place of the aspartate corresponding to D444 in EAAC-1. Wild type EAAC-1 does not bind the 
dicarboxylic acid succinate, but DctA can. When D444 in EAAC-1 is mutated to neutral 
residues, succinate can bind to the mutant carriers and inhibit Na+-induced transient currents, 
which are thought to represent charge-moving conformational changes following 
binding/unbinding of sodium ions. Unlike the R447 mutant carriers, D444 mutant carriers still 
bind acidic amino acids, but no longer transport substrates. Instead, acidic amino acids function 
as non-transportable inhibitors that block the Na+-induced transient currents as well as Na+-
activated anion leak currents. The authors proposed that the interaction of D444 with the amino 
group of substrates is an obligate step for the translocation of acidic amino acids (65). 
The role of other residues proposed to comprise the substrate binding site in GltPh, such 
as R276, T314 and N401, has not been thoroughly investigated in the mammalian EAATs 
(Table I). Mutations of these corresponding residues in human EAAT1 generally abolishes or 
significantly impairs glutamate uptake (42). Further experiments are necessary to clarify whether 
the reduced transport activity of these mutants reflects their inability to bind substrates correctly. 
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Figure 4. Binding sites for substrate and coupled sodium ions 
 (A) The substrate binding site revealed in the GltPh structure is comprised of residues from HP1 (yellow), TM7 
(orange), HP2 (red) and TM8 (magenta). Residues highlighted in red boxes represent those also proposed from the 
results of mutagenesis studies in the mammalian EAATs. (B) Two sodium binding sites revealed in the GltPh 
structure. The two sodium ions are shown as purple spheres. Residues S278 (HP1), G306/N310 (TM7), and 
N401/D405 (TM8) form the Na+ binding site #1, whereas residues T308 (TM7) and S349/I350/T352 (HP2) form the 
Na+ binding site #2. (C) Potential third Na+ binding sites, shown as cyan spheres.  The site #3a is proposed to be a 
transient Na+ binding site that is comprised of T92 (TM3), N310/D312 (TM7), and G404 (TM8), whereas the newly 
suggested site #3b is formed by residues T314 (TM7), A353 (HP2), and N401 (TM8) as well as the substrate itself. 
When a sodium ion binds to the site #1, the sodium ion at the site #3a moves quickly over to the site #3b (see text). 
The illustrations are based the GltPh crystal structure 2NWX, and are made using the software Pymol (Schrödinger, 
LLC). 
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1.4.2 Na+ binding sites 
The coupling of sodium ions to the movement of substrate is a mechanistic feature shared by the 
mammalian EAATs and their prokaryotic ancestors. Y403 in GLT-1 was the first residue to be 
implicated in Na+ binding. The mutant carrier Y403F not only exhibits an approximately 8-fold 
increase in the apparent Na+ affinity, but also allows glutamate transport when Na+ is replaced by 
lithium or cesium ions (66).  Efforts to identify residues near Y403 that influence Na+ binding 
revealed two additional amino acids within the loop structure of HP2 (S440 and S443 in GLT-1). 
It has been demonstrated that Li+ can replace at least one sodium ion, but not all three, to support 
transport activity in GLT-1 (67), whereas all three sodium  ions can be replaced by lithium ions 
to support substrate transport by EAAC-1 (68). Mutation of S440 in GLT-1 to glycine, the 
residue found at this position in EAAC-1, allows Li+ to drive substrate uptake. Transport by this 
mutant carrier also depends on the nature of amino acid at position S443 (69). The reciprocal 
mutation of glycine to serine in EAAC-1 disrupts the ability of Li+ to support substrate transport 
(68). These results suggest that S440 and S443 in GLT-1 play a role in sodium ion 
discrimination. Further studies (Table I) have focused mainly on conserved, negatively charged 
or polar residues that have the potential to interact with cations. The mutant carrier T370S of 
EAAC-1, which is near the equivalent residue of Y403 (GLT-1 numbering), also disrupts Li+ 
dependent substrate transport (68). Moreover, Tao et al. showed that residue T101 and D367 in 
EAAC-1 are involved in the binding of Na+ to the substrate-free form of transporters (70-71). 
The substrate itself, in cooperation with a conserved aspartate residue D439 in EAAC-1, helps 
determine the affinity for binding of additional sodium ions (72).   
Residues that form the Na+ binding sites in GltPh were also suggested by the 
crystallization of the transporter with two thallium ions, which have stronger anomalous 
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scattering properties than sodium ions (49). The Na+ binding site #1 is buried deeply in the 
protein and is comprised of residues (GltPh numbering) S278 (HP1), G306/N310 (TM7), and 
N401/D405 (TM8). Residues T308 (TM7) and S349/I350/T352 (HP2) form the Na+ binding site 
#2 (Figure 4B). Interestingly, although they are nearby to the two proposed sites, most of the 
residues characterized in mutagenesis studies do not agree precisely with the ones proposed for 
GltPh (Table I). These observations illustrate some of the limitations inherent in using 
mutagenesis studies to predict binding sites for substrates and coupled ions. In addition, concerns 
have also been raised as to whether the anomalous difference map seen in Tl+-soaked GltPh 
accurately represents the Na+ binding sites because Tl+ does not support substrate transport in 
GltPh (49). 
Computational approaches, such as molecular dynamics simulations and electrostatic 
mapping, have also been used to model the Na+ binding sites (73-75). These studies revealed two 
putative Na+ binding sites in the vicinity of those suggested by the GltPh structure. In addition, 
molecular dynamics simulations suggest that one sodium ion is stabilized by interacting with 
N310 and D312 in the “NMDGT” motif of TM7, and G404/N401 in TM8 of GltPh (74-76). The 
aspartate D312 is equivalent to D367 in EAAC-1, a residue that has been suggested to bind 
sodium ions prior to glutamate binding (70) and also to form a β-bridge with the residue N310 
(77). T101 of EAAC1 (equivalent to T92 in GltPh) protrudes into a hydrophilic cavity occupied 
by the D367 side chain and is also involved in the initial Na+ binding (78). These results suggest 
a previously uncharacterized Na+ binding site comprised of T92 (TM3), N310/D312 (TM7), and 
G404 (TM8) in GltPh (site #3a in Figure 4C). Larsson et al. further proposed that this Na+ 
binding site is transient (75). When a sodium ion binds to the site #1, the sodium ion at the site 
#3a moves quickly over to a new place that is formed by the substrate itself and residues T314 
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(TM7), A353 (HP2), and N401 (TM8) (site #3b in Figure 4C). The Na+ binding site #3b is also 
suggested by the electrostatic mapping study (73) and agrees with the proposal that the bound 
substrate controls the rate and the extent of Na+ interactions with the transporter (72). 
1.4.3 K+ binding site 
In addition to its proposed contribution to Na+ binding, Y403 in GLT-1 has been implicated in 
the K+-induced reorientation of the substrate-free carriers. Mutation of this residue locks the 
transporter in a Na+-dependent exchange mode and renders the transporter insensitive to K+ (66). 
A similar phenotype has been reported for mutations of the residue E404 in GLT-1, which is also 
involved in H+ binding and will be discussed later in section 1.4.4, and the residue R447 in 
EAAC-1, which interacts with the γ-carboxyl group of glutamate (64, 79). Although Tl+ is 
traditionally viewed as a K+ congener, the thallium binding sites in GltPh are thought to be 
genuine Na+ binding sites because only Na+, but not K+ diminishes the thallium anomalous 
density peaks during crystallization (49). However, GltPh does not require K+ to support substrate 
transport  (80) and it is intriguing that the Na+ binding sites analogous to those identified in the 
GltPh structure may bind K+ in the mammalian EAATs. In support of this idea, Tl+ can replace 
intracellular K+ to mediate glutamate transport in EAAC-1 (81) and residue D455 in GLT-1, 
which corresponds to D405 in the Na+ binding site #1 of GltPh, is required for the interaction of 
the transporter with K+ (81-82). In addition, a 3-dimensional representation of the K+ binding site 
was generated using electrostatic mapping based on a homology model of EAAC-1 (73). The 
proposed site overlaps substantially with the glutamate binding site and is mutually exclusive 
with glutamate binding. These results suggest that the K+ binding site overlaps with the binding 
sites for glutamate, H+ and Na+, and may explain why the K+-induced orientation step is 
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vulnerable to mutations in various regions. It is conceivable that as EAATs reorient to the 
outward-facing state, K+ interacts with regions that were previously occupied by glutamate and 
coupled ions. Recently, a compound present in spider venom, Parawixin1, has been isolated and 
characterized to specifically speed the K+-induced reorientation step of the transport cycle (83). 
Further studies using Parawixin1 and related compounds may help delineate how K+ binds and 
drives the reorientation of substrate-free transporters. 
1.4.4 H+ binding site  
It was originally proposed that a proton ion is transported by EAATs along with the protonated 
form of glutamate (23). Because the γ-carboxyl group of glutamate appears to interact with 
residue R447 in EAAC-1, this mechanism requires that H+ binds to the negatively charged 
glutamate which has bound to the transporter. By contrast, work by Watzke et al. (84) 
demonstrated that EAAC-1 must be protonated before glutamate binds at the extracellular side 
and implied the existence of an ionizable residue in the transporter with apparent pKa of 8. In 
addition, the pKa of this residue shifts by at least 1.5 units after glutamate translocation (84). The 
residue has been identified as E373 in EAAC-1, because amino acid substitutions at E373 render 
substrate transport by the carriers pH-independent (85). E373 is equivalent to E404 in GLT-1, 
which has also been proposed to be crucial for the K+-induced reorientation step (79). Taken 
together, these data support a general mechanism in which E373 in EAAC1 functions as a proton 
acceptor at the extracellular side before glutamate binding, as a proton donor at the intracellular 
side, and once deprotonated, as a binding site for K+ which triggers the reorientation of 
transporters. 
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Table 1. Residues contributing to substrate and coupled ion binding as suggested by GltPh crystal structures, 
computational simulations and by mutagenesis studies in the mammalian EAATs 
 
Residues suggested by computational simulations are marked with asterisks and residues highlighted in red are 
equivalent between two subtypes.  
 
 
 
 
 
 
 Residues in GltPh 
 
 
 
Residues explored in the 
mammalian EAATs 
Proposed role in the mammalian EAATs References 
 
 
 
Substrate 
binding site 
R276, HP1 
S278, HP1 
T314, TM7 
V355, HP2 
G359, HP2 
 
 
 
 
 
D444 in EAAC-1 proposed to interact with the 
amino group of glutamate 
 
R447 in EAAC-1 proposed to interact with the γ-
carboxyl group of glutamate 
(65) 
 
 
 
(64) 
D394, TM8 D444 (EAAC-1), TM8 
R397, TM8 R447 (EAAC-1), TM8 
N401, TM8  
 
 
Na+ binding site 
#1 
S278,  HP1 
G306,  TM7 
N310, TM7 
N401, TM8 
D405, TM8 
Y403 (GLT-1), TM7 
 
 
S440 (GLT-1),  HP2 
S443 (GLT-1) , HP2 
 
D439 (EAAC-1), TM8 
 
Y403 in GLT-1 is implicated in sodium binding 
 
 
S440 and S443 in GLT-1 influence sodium ion 
discrimination 
 
Residue D439 in EAAC-1 controls high-affinity 
sodium binding to glutamate bound transporters 
(66) 
 
 
(69) 
 
 
 
(72) 
 
 
Na+ binding site 
#2 
T308, TM7 
S349, HP2 
I450, HP2 
T352, HP2 
 
 
Transient Na+ 
binding site #3a 
T92*, TM3 T101 (EAAC-1), TM3 T101 and D367 in EAAC-1 appear critical for 
sodium binding to the substrate-free transporters 
 
N365 in EAAC-1 forms a β-bridge with D367 
and is also important for Na+ binding. 
(70, 78) 
 
 
(77) 
N310*, TM7 N365 (EAAC-1), TM7 
D312*, TM7 D367 (EAAC-1), TM7 
G404*, TM8  
 
 
Na+ binding site 
#3b 
T314*, TM7 T370 (EAAC-1), TM7 T370S disrupts the ability of lithium ions to 
support substrate transport. 
 
Both T370 and N451 bind to Na+ before 
glutamate has bound 
(68) 
 
 
(75) 
A353*, HP2  
N401*, TM8 N451 (EAAC-1), TM8 
 
 
 
K+ binding site 
  
Y403 (GLT-1), TM7 
E404 (GLT-1), TM7 
R447 (EAAC-1), TM8 
 
 
D454C (EAAC-1), TM8 
 
These three residues when mutated  lock the 
carriers in an obligatory exchange mode and are 
proposed to be involved in the potassium-induced 
translocation of substrate-free transporters 
 
D454 contributes to potassium binding. 
 
 
(64, 66, 79) 
 
 
 
(81-82) 
 
H+ binding site 
  
E373 (EAAC-1), TM7 
 
E373 in EAAC-1 proposed to be a H+ acceptor 
 
(85) 
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1.5 MECHANISMS OF SUBSTRATE TRANSPORT 
Secondary active transporters including glutamate transporters are thought to function through an 
alternating access mechanism (86). In this model, the substrate binding site is alternatively 
accessible from the extracellular and intracellular sides through a process that depends on one or 
more conformational changes. Several studies have been carried out to probe the conformational 
transitions that occur during substrate transport. Early work by Grunewald and Kanner compared 
how trypsin cleaves EAATs into different sets of proteolytic fragments in the absence or 
presence of substrates, and demonstrated that conformational changes triggered by substrate 
transport expose additional trypsin sites (67). Larsson et al. used voltage-clamp fluorometry to 
directly measure fluorescence changes in a neuronal EAAT covalently labeled with a fluorescent 
reporter. Their results showed that alterations in concentrations of glutamate and co-transported 
ion and in the membrane voltage induce conformational rearrangements in EAATs (87). More 
recently, Mim et al. determined the activation parameters of rapid, glutamate-induced processes 
by analyzing the temperature dependence of glutamate transport at steady state and pre-steady 
state. They proposed that two conformational changes accompany glutamate translocation and at 
least one conformational change accompanies relocation of the empty transporter based on the 
large calculated enthalpies associated with these processes (88). Although these studies do not 
have sufficient resolution to reveal the nature of these conformational changes, they do suggest 
the potential for multiple discrete conformational transitions during the transport cycle.  
The substrate binding site of GltPh is cradled by the two helical hairpins (HP1 and HP2).  
These hairpins have thus been proposed to act as inner and outer gates for glutamate transporters, 
and the GltPh structure with substrate bound (PDB ID: 1XFH) represents an occluded state with 
two gates closed. The structural evidence supporting HP2 as the outer gate comes from the 
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TBOA-bound GltPh structure (PDB ID: 2NWW). The structure provided a clear view showing 
that when TBOA is bound, HP2 is locked in an open conformation, thus precluding the binding 
of a sodium ion and further conformational changes (Figure 5A). The opening of HP2 was also 
suggested by molecular dynamics simulations based on the apo-state (unliganded state) of the 
GltPh structure and is considered to be an intrinsic feature of glutamate transporter dynamics that 
occurs within tens of nanoseconds in simulations (74, 89). Indeed, substituted cysteine 
modification studies performed on human EAAT1 and GLT-1 showed that substrates and 
coupled ions can modify solvent accessibilities of the residues in HP2, consistent with the idea 
that this region undergoes conformational changes during substrate translocation in the 
mammalian EAATs (90-91). 
On the other hand, more limited data exist to support HP1 as the inner gate. Biochemical 
studies showed that a conserved motif of three consecutive serine residues at the HP1 tip can be 
accessed by hydrophilic agents from both sides of the membrane in the bacterial transporter 
GltTBs (47). In addition, Shlaifer and Kanner (92) probed the reactivity of cysteines introduced 
into the C-terminal part of GLT-1 to membrane permeable agent N-ethylmaleimide (NEM). 
They reported an increase in the modification of cysteine substituted mutants in TM7, TM8 and 
HP1 when external Na+ is replaced by K+, a condition expected to increase the proportion of 
inward-facing transporters. By contrast, the modification of these cysteines was decreased by 
non-transportable analogs, which presumably lock transporters in the outward-facing state. 
Based on these observations, the authors suggested that the inward movement of HP1 leads to 
the opening of a pathway between the binding pocket and the cytoplasm, lined by parts of TM7 
and TM8. Interestingly, our lab demonstrated that a disulfide crosslink that limits the movement 
of HP1 appears to abolish transport, whereas constraint of HP2 movement alters the apparent 
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affinity for substrates with no effect on the maximal transport rate. These results link the 
movement of HP2 to initial substrate binding events and the movement of HP1 to later steps in 
translocation, consistent with the view that these two domains may function as outer and inner 
gates of the translocation pore, respectively (52).   
While HP2 can move freely toward the large aqueous basin formed by the three subunits, 
HP1 is tightly packed with TM7, TM8 and the surrounding scaffold structure in the substrate-
bound GltPh structure (Figure 5B). It was therefore proposed that HP1 first moves vertically 
towards the cytoplasm and then laterally away to create a pathway along the polar face of TM7 
and TM8, exposing the serine-rich HP1 tip (48). Evidence for such vertical movement of HP1 is 
revealed in a recent inward-facing structure of GltPh (PDB ID: 3KBC) in which two substituted 
cysteines (K55C/A364C) in TM2 and HP2 regions are crosslinked by divalent mercury (Hg2+) 
(50). The most striking feature of this structure compared to the original substrate-bound GltPh 
structure is that not only HP1, but the whole C-terminal transport domain moves approximately 
18 Å towards the cytoplasm (Figure 5C). Such movements significantly increase the exposure of 
the transport domain to the cytoplasm allowing the potential gating movement of HP1, which 
contradicts the earlier proposal that only small-scale molecular motions are required to 
accomplish glutamate uptake in EAATs (93). The inward-facing conformation of GltPh is 
recapitulated by a modeling study based on the symmetric considerations of the transporter 
(inverted-topology structural repeats) (94). The equivalent residue pairs of K55C/A364C can 
also be crosslinked in human EAAT1 and EAAC-1 (94-95), reinforcing the idea that GltPh and 
the mammalian EAATs share similar dynamic movements during substrate transport.  
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Figure 5. Mechanisms of substrate transport 
(A) The TBOA-bound GltPh structure (PDB ID: 2NWW) showing HP2 displaced from the substrate binding site 
(TBOA is removed from the structure for clarity). (B) The substrate-bound GltPh structure (PDB ID: 2NWX) 
showing the closed HP2, two sodium ions and the bound substrate, L-aspartate. (C) The inward-facing GltPh 
structure (PDB ID: 3KBC) in which the whole C-terminal transport domain moves towards the cytoplasm. (D) 
Surface representation of the outward-facing GltPh (as the substrate-bound conformation) before the transport 
domain moves into the cytoplasm. (E) Surface representation of the inward-facing GltPh. The three protomers are 
colored in either green, magenta or cyan. The illustrations are made using the software Pymol (Schrödinger, LLC). 
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Thus, a general picture of how glutamate transporters uptake substrate emerges (Figure 
5). HP2 opens up spontaneously to expose the substrate binding site. After glutamate and co-
transported ions bind, HP2 closes and seals the substrate binding site, and the transporter is in an 
occluded, outward-facing conformation (Figure 5D). The whole transport domain then moves in 
a piston-like motion toward the cytosol which permits the opening of the internal gate, 
presumably HP1, and the transporter is in an occluded, inward-facing conformation (Figure 5E). 
After the release of substrate, K+ binds to and facilitates reorientation of the carrier back to the 
outward-facing state. 
1.6 THE STRUCTURAL BASIS FOR THE TRANSPORTER-ASSOCIATED ANION 
CONDUCTANCE 
In addition to transporting substrates, glutamate transporters have also been shown to possess an 
anion channel activity (11, 28). The anion current is activated by coupled Na+ (the Na+-activated 
anion leak current) and is significantly increased with the addition of substrates (the substrate-
activated anion current). At present it is not known if the two anion currents share the same 
pathway or go through different ones. The relative anion permeability sequence for the Na+-
activated anion leak current determined in human EAAT1 is I- > NO3- > Br- > Cl- and is 
different from that for the substrate-activated anion current (NO3- > I- > Br- > Cl-). If the two 
anion currents share a similar pathway, the selective filter that controls anion interaction must 
experience subtle changes when substrate binds to the transporter. Nevertheless, the anion 
channel activity of glutamate transporters is thermodynamically uncoupled from the substrate 
transport process. Modification of substituted cysteines in the HP2 region completely abolishes 
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uptake activity in the mutated carriers, but preserves the glutamate-activated anion current (96-
98). Studies have also shown that the substrate-activated anion current can still occur at 4 ºC or 
at membrane potential >70 mV when glutamate uptake is abolished (29). In addition, the 
temperature coefficient (Q10) of EAAC-1 for the Na+-activated anion leak current and the 
substrate-activated anion current are 1.9 and 1.7 at 0 mV membrane potential, respectively (88). 
These values are similar to the Q10 value for diffusion-limited processes in an aqueous solution 
(1.3 to 1.6) and are smaller than that of substrate transport (3.7 at 0 mV and 3.2 at -30 mV) (29, 
88). Thus, while substrate transport requires substantial conformational changes and is 
temperature dependent, small structural rearrangements might be sufficient to maintain the anion 
channel activity of glutamate transporters.  
The molecular determinants of the transporter-associated anion conductance have been 
explored by Vandenberg and colleagues (95, 99). They initially focused on polar or charged 
residues in the TM2 region of human EAAT1 because such residues form ion permeation 
pathways of many ion channels (100-101).  Mutations of several polar or charged residues in 
TM2 affected various properties of the anion channel activity, but not the transport of glutamate 
(95). Consistent with the idea that they form a chloride permeating pore, most of the 
characterized residues are solvent accessible, as judged by their reactivity to either thiol-
modifying methanethiosulfonate reagents or HgCl2. Two mutant carriers show particularly 
interesting phenotypes. The glutamate-activated anion currents in the mutant carrier S103V 
display an altered sequence of anion permeation, Cl- < NO3- < Br- < I- (for the wild type EAAT1, 
Cl- < Br- < I- < NO3-), suggesting that S103 contributes to the selectivity filter of the channel. In 
addition, the mutant carrier D112A has a greatly increased Na+-activated anion leak current, but 
a decreased substrate-activated anion current. It was proposed that D112 may serve as a gating 
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residue for the anion channel. When mutated, the channel is locked in an open state, which leads 
to a large increase in anion leak current. Thus, little additional current can be activated by 
glutamate (95). This interpretation assumes that the Na+- and substrate- activated anion channel 
pathways are closely related. Alternatively, the D112A mutation may facilitate opening of the 
leak conductance pathway, but prevent opening of a separate substrate-activated anion pathway 
(102). 
An additional study investigated charged residues that are within 5 Å of S103 and D112 
based on a 3-dimensional homology model of human EAAT1. Residues D272 in TM5 and 
K384/R385 in TM7 show an altered anion leak conductance and substrate-activated anion 
conductance when mutated to neutral or oppositely charged amino acids (99). Unlike the D112A 
transporter, the mutant carriers D272A and D272K display increased amplitudes of both the leak 
and substrate-activated anion conductance. On the other hand, mutants K384A and R385A have 
increased leak conductance with little change in the substrate-activated anion current. Mutants 
K384D and R385D have both increased leak and substrate-activated anion conductance even 
though the increased amplitude of the leak conductance is smaller than that of the respective 
alanine mutants. These results suggest that both the position and charge of residues in the 
intracellular region of EAAT1 influence the two components of the anion conductance. 
 Because GltPh also have anion channel activity (32), it is intriguing to look at the anion 
channel function of EAATs in light of the GltPh structures. The mutant carrier S65V in GltPh 
(equivalent to S103V in human EAAT1) displays reduced substrate-activated Cl- influx 
compared to the wild type transporter, suggesting that the chloride permeation pathway is 
conserved in GltPh and human EAAT1 (32). The residue equivalent to D112 is located at the 
TM2-TM3 loop, which undergoes significant conformational changes to accommodate the large 
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movement of the C-terminal transport domain as revealed by the inward-facing GltPh structure. 
Whether this large inward movement of the transport domain is linked to the transporter 
associated anion conductance warrants further exploration. 
1.7 THESIS GOALS  
Although several high resolution structures of GltPh in different conformations provides clarity in 
regards to the structural domains involved in substrate transport, our knowledge on the 
conformational dynamics of the carrier is far from complete. The regions that participate in 
permeation and gating of the anion channel activity are also not yet established, nor is the 
structural linkage between substrate transport and the anion channel function. The goal of this 
thesis is to use biochemical, electrophysiological and functional assays in combination with 
computational simulations to identify key domains and conformational changes involved in the 
glutamate transporter’s dual functions.    
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2.0  LARGE COLLECTIVE MOTIONS REGULATE THE FUNCTIONAL 
PROPERTIES OF GLUTAMATE TRANSPORTER TRIMERS 
2.1 INTRODUCTION 
Glutamate transporters, like many other proteins, carry out their biological activities by sampling 
an ensemble of conformations (67, 87-88).  The equilibrium motions accessible to the transporter 
can vary over a wide range of length- and time- scales, e.g., from fluctuations in bond lengths, 
bond angles and dihedral angles (local motions) to cooperative movements of entire domains or 
subunits (global motions). The crystallization of GltPh in several different conformational states 
greatly expanded our understanding of substrate transport achieved via an alternating access 
mechanism.  Local conformational changes in HP1 and HP2 allow for the opening or occlusion 
of the substrate-binding site, whereas the piston-like movement of the transport domain provides 
a means for transition between the outward- and inward-facing states (Figure 5). However, 
transport is inherently a dynamic process and cannot be completely understood solely on the 
basis of static pictures, even if they are of high resolution.  
Ideally, researchers would like to observe individual atoms moving within a protein to 
study the conformational changes associated with protein functions. This goal is not possible to 
achieve experimentally at present and the dynamics of proteins are largely inferred from 
sophisticated biophysical methods that measure physical properties (103). In one such study of 
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glutamate transporters, Larsson and colleagues employed fluorescence/Förster resonance energy 
transfer (FRET) analysis to determine the relative positions of different TM domains of human 
EAAT3. FRET is a phenomenon by which a donor fluorophore transfers its excitation energy to 
a nearby acceptor fluorophore. The efficiency of FRET depends on and can be used to estimate 
the relative distance of the donor and acceptor fluorophores. This study suggested very little 
structural changes in glutamate transporters during substrate transport (93). Mutagenesis studies 
can also provide valuable information on the in-depth mechanism of proteins if mutations or 
sulfhydryl modifications of cysteine substitutions lock biomolecules in specific conformational 
states (104). One good example of this strategy is to constrain the movement of certain areas of 
proteins by crosslinking two exogenously introduced cysteines that are spatially close with each 
other. Using this method, our lab has successfully restricted the movements of the HP2 or HP1 
domains and provided insights into the mechanism of the substrate translocation (52). Finally, 
computational simulations have the unbeatable power to putatively describe protein dynamics in 
detail, because they can simulate the precise position of each atom at any instant time, provided 
that a high resolution structure of the protein is known (103). In this chapter, we utilized cysteine 
crosslinking study in combination with computational modeling to identify a series of large-scale 
collective motions that are intrinsic to glutamate transporter trimers. 
Using a cysteineless version of the human excitatory amino acid transporter EAAT1, we 
show that single cysteine residues introduced into the extracellular gate (helical hairpin HP2) on 
each of the three subunits form reversible intersubunit crosslinks spontaneously and/or catalyzed 
by the oxidizing reagent copper phenanthroline (CuPh). After crosslinking, substrate uptake, but 
not the substrate-activated anion conductance, is completely inhibited in these mutants. The 
formation of disulfide bridges between pairs of cysteines that are more than 40 Å apart in the 
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static structure can be explained by the concerted subunit movements predicted by anisotropic 
network model (ANM) analysis. The existence of these global motions is further supported by 
the observation that single cysteine substitutions at the N-terminal part of TM8 helix can also be 
crosslinked by CuPh, as predicted by the ANM analysis. Interestingly, the transport domain in 
the third (uncrosslinked) subunit of the trimer assumes an inward-facing orientation, suggesting 
that individual subunits potentially undergo separate transitions between outward-facing and 
inward-facing forms, rather than an all-or-none transition of the three subunits, a mechanism also 
supported by ANM-predicted intrinsic dynamics. These results shed light on how large collective 
motions contribute to the functional dynamics of glutamate transporters. 
2.2 RESULTS 
2.2.1 Inhibition of substrate transport by CuPh and cadmium ions in mutants V449C and 
I453C  
Previously, our lab used CuPh-catalyzed crosslinking of cysteine pairs introduced into a highly 
functional cysteineless version of human EAAT1 (CSLS) to examine the interaction of key 
domains associated with substrate translocation (52). To serve as a control, single cysteine 
mutants were also treated with CuPh to confirm that crosslinking occurs between cysteine pairs 
within a single subunit. We unexpectedly found that for one single cysteine mutant, V449C, 
incubation with 300 μM CuPh for 5 min completely abolishes transport activity. V449C-
transfected COS7 cells show 36.68 ± 2.84% of the transport activity of the CSLS control when 5 
μM L-glutamate is used as substrate (Figure 6B). After 5 min exposure to 300 μM CuPh, 
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V449C-expressing COS7 cells display minimal transport, even at high substrate concentrations 
(up to 1 mM, Figure 6E). In contrast, no change in transport is observed for CSLS-transfected 
cells after CuPh treatment (Figure 6A and 6D). To confirm that the effect of CuPh is associated 
with the formation of disulfide bonds, we incubated cells expressing V449C first with 300 μM 
CuPh and then with 20 mM dithiothreitol (DTT) for 5 min to reduce crosslinks. To our surprise, 
incubation with DTT not only recovers, but also increases substrate accumulation by this mutant. 
Consistent with this observation, treatment with DTT alone also enhances the uptake activity of 
V449C, suggesting disulfide bonds form spontaneously (Figure 6B).  
We also explored the effect of CuPh on another mutant, I453C, a residue one helical turn 
away from V449. Before crosslinking, the I453C mutant exhibits 60.67 ± 2.64% of the transport 
activity of CSLS. After 5 min treatment with 300 μM CuPh, this mutant displays modest 
transport activity (~50% compared to the untreated control, Figure 6C). Analysis of the kinetic 
properties of the mutant carrier I453C shows that CuPh treatment results in a decrease of Vmax 
(35% - 62.5% of the untreated control), but the Km remains essentially the same (34.82 ± 9.82 
µM for the untreated control vs. 33.25 ± 5.48 µM for the CuPh treated group). The residual 
uptake activity after CuPh treatment arises from uncrosslinked I453C, because prolonged 
incubation with CuPh or additional treatment with a thiol-modifying reagent, MTSET, further 
reduces its uptake activity (Figure 7). The inhibition of I453C by CuPh can be completely 
reversed by 20 mM DTT, though no enhancement of transport activity is seen as for V449C 
(Figure 6C). 
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Figure 6. Inhibition of substrate transport by CuPh and cadmium ions in mutants V449C and I453C 
COS7 cells expressing CSLS, V449C and I453C were treated with 20 mM DTT, 300 μM CuPh, or 300 μM CuPh 
followed by DTT, for 5 min. Uptake assays were performed for 10 min at room temperature using 5 μM L-[3H] 
glutamate as substrate in panel A-C or using various concentrations of L-[3H] glutamate as substrate in panel D-F. 
The effect of Cd2+ on transport activity was determined by including 100 μM cadmium chloride in the uptake 
solution.  Data for V449C and I453C are expressed as the percent of uptake activity relative to the CSLS control in 
Panel A-C.  
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Figure 7. The effect of prolonged incubation of CuPh or additional incubation with MTSET on uptake 
activity of the I453C mutant carrier  
(A) COS7 cells expressing I453C were treated with 300 μM CuPh for indicated time. (B) Cells expressing I453C 
were treated with 300 μM CuPh, 1 mM MTSET or 300 μM CuPh followed by MTSET, for 5 min. Uptake assays 
were performed for 10 min at room temperature using 5 μM L-[3H] glutamate as substrate.  Data are expressed as 
the percent of uptake activity relative to the untreated control.  
As a complementary method to determine the proximity of cysteine residues, we 
performed transport assays with V449C or I453C in the presence of 100 μM cadmium ions. This 
divalent cation interacts with cysteinyl side chains and the affinity of the interaction is 
dramatically increased if Cd2+ can be coordinated by two cysteines (95). The presence of Cd2+ in 
the uptake solution abolishes the transport activity of V449C (Figure 6B) and significantly 
inhibits that of I453C (Figure 6C).   
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2.2.2 Single cysteine substitutions at the N-terminal end of helix HP2b are more reactive 
to CuPh and form spontaneous crosslinks 
Residues V449 and I453 are located at the N-terminal end of helix HP2b, which along with 
HP2a forms the helical hairpin HP2 (Figure 8A). To determine whether other residues in HP2b 
can also crosslink, we measured the effect of CuPh on single cysteine mutants within the HP2b 
helix from A446 to V458. All but three cysteine mutants in this region are able to accumulate L-
glutamate above background levels when expressed in COS7 cells (90). Upon treatment with 
CuPh, the most reactive cysteine substitutions are L448C and V449C, and their uptake activities 
are completely inhibited after 5 min incubation with 300 μM CuPh (Figure 8C). The mutant 
carrier V449C readily forms disulfide bonds because CuPh concentrations as low as 5 μM CuPh 
are sufficient to completely inhibit transport activity (Figure 8B). The second order rate constant 
of CuPh is 1790 ± 263 M-1s-1 for V449C. By contrast, residues near the C-terminal end of HP2b 
(L455C, T456C and V458C) still accumulate substrate comparably to untreated controls, 
indicating they do not achieve sufficient proximity to form disulfide bonds. Mutants V452C, 
I453C, and V454C in HP2b show intermediate inhibition by CuPh. The inhibition of all these 
mutants by CuPh can be reversed by additional incubation with 20 mM DTT, as demonstrated in 
Figure 8D. Furthermore, DTT significantly increases transport activity of L448C, to an even 
greater degree than that observed for V449C, suggesting that L448C also forms spontaneous 
crosslinks.  
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Figure 8. Single cysteine substitutions at the N-terminal end of the helix HP2b are more reactive to CuPh and 
form spontaneous crosslinks.  
 (A) Locations of V449 and I453 on the helix H2b of the HP2 hairpin, shown for one subunit (viewed in the plane of 
the membrane). (B) COS7 cells expressing V449C were treated with different concentrations of CuPh for 5 min and 
uptake activity was measured. (C) The effects of 300 μM CuPh for 5 min on the L-glutamate transport activity of 
transporters with a series of single cysteine substitutions in HP2b. (D) Substrate transport by mutant transporters 
after additional treatment with 20 mM DTT for 5 min. Uptake assays were performed for 10 min at room 
temperature using 5 μM L-[3H] glutamate as substrate. Data are represented as the percentage of untreated controls 
in two to four experiments done in triplicate.  
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2.2.3 The formation of disulfide bonds in V449C and I453C as confirmed by biochemical 
assays 
We next sought to obtain biochemical evidence of disulfide bond formation after CuPh 
treatment. Because of their propensity to form both spontaneous and CuPh-catalyzed crosslinks, 
we focused on the V449C and I453C mutant carriers. V449C and I453C each contain only one 
cysteine residue per subunit within the trimer, the covalent disulfide bridges must span two 
subunits, and should be readily detectable as dimers by non-reducing SDS-PAGE. However, 
glutamate transporters tend to form oligomers in polyacrylamide gels when overexpressed in 
COS7 cells. We thus turned to Xenopus oocytes which predominantly show transporter species 
corresponding to monomers when analyzed by SDS-PAGE (57), and used a method for isolating 
plasma and microsomal membranes from oocytes originally described by Kobilka et al. (105).  
In oocytes, CuPh and DTT have similar effects on the uptake activity of V449C and I453C as in 
COS7 cells (Figure 9). When oocyte membrane proteins are separated by non-reducing SDS-
PAGE and immunoblotted, the CSLS control exhibits two species at molecular mass of ~70 kDa 
and ~50 kDa, corresponding to fully glycosylated and unglycosylated/partially glycosylated 
monomers, respectively (Figure 9). With V449C and I453C, bands migrating at ~70 kDa and 
~50 kDa are seen in untreated oocytes, whereas an additional ~140 kDa species appears after the 
oocytes are treated with 300 μM CuPh for 5 min, consistent with the predicted size of a 
crosslinked transporter dimer. A weak dimer band signal is also observed in untreated V449C-
expressing oocytes, confirming the existence of spontaneous crosslinks. The high molecular 
weight band disappears in V449C-expressing oocytes and is significantly less in I453C-
expressing oocytes after additional incubation with 20 mM DTT. These results strongly suggest 
that V449C and I453C form CuPh-catalyzed, DTT-reversible disulfide bonds.  
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Figure 9. CuPh catalyzes the formation of disulfide bonds in V449C and I453C as confirmed by biochemical 
assays 
Transporters were expressed in Xenopus oocytes and treated with 300 μM CuPh, or 300 μM CuPh followed by DTT, 
for 5 min. Oocyte membranes were lysed and separated by non-reducing gradient SDS-PAGE, and subjected to 
western blotting analyses. Glutamate transporter proteins were identified using an anti-EAAT1 polyclonal antibody 
directed against the C-terminus. Uptake assays in oocytes were carried out at room temperature using 5 μM L-[3H] 
glutamate as substrate for 15 min and data are normalized to untreated controls. 
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The mutant I453C shows a stronger dimer band signal compared to V449C after 
crosslinking, although transport by I453C is less dramatically inhibited. In addition, a weak 
dimer band signal of I453C is observed after additional DTT treatment even though DTT 
completely reverses the inhibition of uptake by CuPh. During CuPh incubation, a portion of 
crosslinked I453C may be internalized and are no longer accessible to DTT. The weak dimer 
band signal in V449C could also result from the instability of disulfide bonds in this mutant 
carrier during the process of biochemical assays. We therefore treated V449C-expressing oocytes 
with a bifunctional crosslinking reagent, 1,8-Octadiyl Bismethanethiosulfonate (M8M).  5 min 
incubation with 1 mM M8M significantly inhibits the uptake activity of the mutant carrier 
V449C (Figure 10A) and induces a prominent dimer species when analyzed by non-reducing 
SDS-PAGE (Figure 10B).  
 
 
Figure 10. The effect of a 
bifunctional crosslinking reagent, 
M8M, on the mutant V449C.  
(A) Oocytes expressing V449C were 
treated with 300 μM CuPh or 1 mM 
M8M for 5 min. Uptake assays were 
performed at room temperature using 
5 μM L-[3H] glutamate as substrate 
for 15 min. (B) After indicated 
treatment, oocyte membrane samples 
were collected and subjected to 
western blotting analyses using an EAAT1-specific antibody.  (C) The chemical structure of M8M. 
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2.2.4 Crosslinks in the mutant carrier V449C take place between two transporter 
subunits in the same trimer 
Although the additional high molecular weight species appeared after CuPh treatment in the 
mutant carrier V449C migrates at the predicted size of the transporter dimers, it is possible that 
the crosslinks might take place between a transporter subunit and an unknown protein with a 
similar apparent molecular mass.  To exclude this possibility, we constructed an N-terminus GFP 
tagged V449C. When expressed in Xenopus oocytes, 5 min incubation with 300 µM CuPh 
significantly inhibits the uptake activity of GFP-V449C, similar to that is observed for non-
tagged V449C (Figure 11A). We then expressed V449C, GFP-V449C or a 1:1 ratio of 
V449C/GFP-V449C mixture in oocytes and treated the cells with 1 mM M8M for 5 min, which 
induces stronger crosslinked dimer band signals (Figure 10). When membrane protein samples 
are separated by non-reducing SDS PAGE, three different species of crosslinked dimers are 
detected, corresponding to V449C/V449C, V449C/GFP-V449C, and GFP-V449C/GFP-V449C 
(Figure 11B). If the subunits were crosslinked to an unknown protein, we would expect to see 
two crosslinked species, one between V449C and the unknown protein, and the other between 
GFP-V449C and the unknown protein. Thus, CuPh catalyzes V449C crosslinks between two 
transporter subunits.  
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Figure 11. CuPh-catalyzed V449C 
crosslinks take place between two 
transporter subunits   
(A) Oocytes expressing V449C or GFP-
V449C were treated with 300 μM CuPh for 5 
min. Uptake assays were performed for 15 
min at room temperature using 5 μM L-[3H] 
glutamate as substrate. (B) V449C, GFP-
V449C or a 1:1 ratio of V449C/GFP-V449C mixture were expressed in oocytes. After treatment with 1 mM M8M 
for 5 min, oocyte membrane samples were collected and subjected to western blotting analyses using an EAAT1-
specific antibody.   
 
 
 
Figure 12. human EAAT1 forms trimers   
CSLS glutamate transporters were expressed in 
Xenopus oocytes. Oocyte membranes were collected 
for blue native polyacrylamide gel electrophoresis 
(BN-PAGE) analyses (left two lanes). The native 
samples were further treated with SDS and heat as 
indicated to dissociate the oligomer structure (right 
three lanes). The western blotting was probed with a C-terminally-directed EAAT1-specific antibody. 
 
 
 
 
 47 
The GltPh structure is comprised of three identical subunits and the trimeric stoichiometry 
has also been suggested for both bacterial (GltTBc, GltTBs and GltPEc) and mammalian (GLT-1 
and EAAC1) glutamate transporters (55-57). The subunit stoichiometry of human EAAT1 has 
not been explored, although its homologous subtype in rat (GLAST) forms either dimers or 
trimers (54). Thus it is possible that the CuPh-catalyzed disulfide bonds observed in our study 
might form between two protomers of adjacent transporter multimers. Previous studies using 
freeze-fracture, immuno-gold labeling and electron microscopy have shown that glutamate 
transporters concentrate in ~200 nm protein-rich islands in the plasma membrane (106), 
suggesting that transporters can be very close spatially. To determine if crosslinks take place 
within a single transporter multimer or between adjacent multimers, we used blue native 
polyacrylamide gel electrophoresis (BN-PAGE) analysis, which permits gel electrophoresis 
under non-denaturing conditions and thus the determination of the oligomeric structure of 
proteins.  
Similar to what has been reported for human EAAT2 (57), the CSLS transporter 
expressed in Xenopus oocytes migrates predominantly as a single band in blue native 
polyacrylamide gels. When the protein samples were incubated at 56 °C for 1 hour in the 
presence of 1% SDS, two bands at lower molecular weight appear, corresponding to the dimer 
and monomer forms of the transporter. Increasing SDS concentration to 2% completely 
dissociates transporters to monomer form (Figure 12). These data suggest that human EAAT1 
exists in the plasma membrane as trimers. Thus, if crosslinks occur between adjacent transporter 
multimers, single cysteine-substitution mutants would form at minimum, a hexameric structure 
after CuPh treatment. 
 
 48 
 
 
 
Figure 13. CuPh induced crosslinks occur within the trimeric structure 
CSLS and mutant transporters were expressed in Xenopus oocytes. Oocytes were treated with 300 μM CuPh, or 300 
μM CuPh followed by DTT, for 5 min. Oocyte membranes were collected for BN-PAGE analysis (A) and The 
native samples were further incubated at 56 ºC for 1 hour in the presence of 2% SDS, which completely disrupted 
trimeric CSLS transporters to monomers. Glutamate transporter proteins were identified using an anti-hEAAT1 
polyclonal antibody directed against the C-terminus. (B) Estimated distances (in Å) between the three V449 
residues, and the three I453 residues in an EAAT1 trimer, a model based on the crystal structure of GltPh in the 
outward-facing state (PDB ID: 1XFH). The transporter is viewed from the extracellular region. GltPh counterparts of 
V449 and I453 are I361 and M365, respectively. 
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The mutants V449C and I453C display trimer species of similar intensity before and after 
treatment with 300 μM CuPh and no higher molecular weight crosslinked species observed when 
analyzed by BN-PAGE (Figure 13A). We further dissociated the native samples by incubating 
them at 56 ºC for 1 hour in the presence of 2% SDS, which completely disrupted trimeric CSLS 
transporters to monomers when separated in SDS gels. We found that V449C and I453C with 
CuPh treatment display dimer bands in addition to their monomer forms (Figure 13A), 
suggesting that the trimeric species obtained by blue native gel analysis after CuPh treatment in 
the mutants V449C and I453C is comprised of two covalently linked subunits and one 
uncrosslinked subunit. V449C and I453C thus form disulfide bridges within their trimeric 
structures after CuPh treatment. 
In the absence of substrate, glutamate transporters spend the majority of time in the 
outward-facing orientation, waiting to clear extracellular glutamate. Interestingly, the Cα atoms 
of the intersubunit disulfide bridge forming residues, V449C and I453C, are separated in the 
equilibrium structure by more than 40 Å based on the outward-facing crystal structure of GltPh 
(PDB ID: 1XFH, Figure 13B). In order to form a CuPh-catalyzed disulfide bond, the α-carbons 
of the two cysteines would need to be within 7 Å of each other (107) and this distance would 
need to be even shorter (within 5 Å) to form spontaneous crosslinks (108). The observed 
formation of intersubunit disulfide bridges suggests that large conformational transitions must 
take place to bring the HP2b helices of two subunits together and enable covalent bonding 
between cysteines of different subunits. To gain insight into the mechanism that allows these 
residues to interact, we examined the dynamics of the transporter at multiple scales using 
computational simulations based on the available crystal structures of GltPh. Although GltPh 
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shares only ~25% sequence identity with human EAAT1 (Figure 14), its structural features and 
trimeric organization agree with many aspects of the models originally proposed based on 
biochemical assays (109). Thus, GltPh provides a framework for investigating the structural 
changes associated with carrier functions. 
 
Figure 14. Sequence alignment of GltPh and human EAAT1 
Boxes above the alignment correspond to transmembrane domains and sequences highlighted in blue are regions of 
exact identity between the two carriers. The mutants used for experiments in part 2 of this dissertation are indicated 
with red arrows (V449C and I453C in HP2 region, and the mutants I469C, A470C and W473C in TM8). The 
alignment was made using ClustalW and adjusted manually. Sequences used in the alignment are P. horikoshii GltPh 
(pubmed access number: NP_143181) and human EAAT1 (P43003). 
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2.2.5 Molecular dynamics (MD) simulations show spontaneous opening of the HP2 loop 
We first explored the dynamic motions of glutamate transporters using molecular dynamics 
simulations. This computational method calculates the time dependent behavior of a molecular 
system and can provide detailed information on the fluctuations and conformational changes of 
proteins (110). The simulations were performed for 40 ns using the outward-facing structure of 
GltPh (PDB ID: 1XFH) embedded in a lipid bilayer as the initial conformation. The most striking 
motion observed in the simulation is the large amplitude fluctuations of the HP2 loop moving 
away from the substrate binding site toward the aqueous basin (Figure 15A). This type of 
motion is evidenced by the change in the distance between residues S278 and G354 at the tips of 
the respective helical hairpins HP1 and HP2 (Figure 15B). When HP2 is closed and shields the 
substrate binding site, the distance between the hydrogen bond-forming backbone nitrogen and 
oxygen on the respective residues G354 and S278 is ~1.9 Å in all three subunits. The distance is 
increased by more than 9 Å in subunit A (black curve in Figure 15C) succeeding the 
reconfiguration of the HP2 loop. The HP2 loop in subunit B (red curve) exhibits a displacement 
of about 7 Å at 17 ns, whereas that in subunit C (green curve) remains closed throughout the 
entire duration of the MD simulations (Figure 15C). Once the original tight packing of the two 
hairpins is disrupted, the HP2 loop tends to remain open and disordered as indicated by the large 
fluctuations in the HP1-HP2 distance for both subunits A and B. The opening of HP2 loop 
exposes the substrate binding site to the aqueous basin, suggesting that HP2 serves as the 
external gate.  
In light of our crosslinking results, we examined the MD trajectories to determine the 
time evolution of the Cα distance between the same residues of adjacent subunits that have 
shown to form intersubunit crosslinks. We found that the Cα atoms of residue I361 (equivalent to 
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V449 in human EAAT1, Figure 14) between two subunits reach a minimum of ~30Å, a distance 
too far to allow for disulfide bond formation. Larger movements, which are outside the range of 
MD simulations, are required to explain the data. Thus, we turned to anisotropic network model 
(ANM) analysis (111-112) to investigate the collective dynamics of GltPh. 
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Figure 15. Molecular dynamics (MD) simulations show spontaneous opening of the HP2 loop 
Simulations were performed for 40 ns using the outward-facing structure of GltPh (PDB ID: 1XFH) embedded in a 
lipid bilayer as the initial conformation. (A) Three snapshots at t = 0, 3, and 7 ns of simulations display an increase 
in the separation between the helical hairpins HP1 and HP2 (see circled region). (B) Positions of residue S278 and 
G354 at the tips of the respective helical hairpins HP1 and HP2. The two residues are highlighted as blue spheres. 
(C) Time evolution of the distance between hydrogen bond-forming backbone S278(N) and G354(O), observed in 
subunit A (black), B (red), and C (green). 
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2.2.6 ANM analysis suggests that large collective motions of glutamate transporter 
trimers significantly alter intersubunit distances 
ANM analysis explores collective fluctuations or so-called global motions that are intrinsically 
accessible to a given protein structure under physiological conditions. In this approach, the 
structure is modeled as a network of harmonic oscillators. The nodes of the network are 
identified by the Cα atoms and the springs, usually taken to be uniform (identical force 
constants), account for inter-residue interactions. The collective dynamics of such a network is 
uniquely defined by the network topology, and resolved by a normal mode analysis into 3N-6 
modes of motions (N is the total number of amino acids of the given protein). The top-ranking 
modes are characterized by low frequency/large amplitude movements that generally occur 
within a micro- to millisecond time range. These so-called the soft modes usually play a 
dominant role in defining the structural changes involved in the biological activity of the protein, 
as has been demonstrated for both water-soluble and membrane proteins (113-114) . 
Three ANM global modes accessible to GltPh are distinguished by their high collectivity. 
The first two (modes 1 and 2) are degenerate, i.e., they have the same frequency and complement 
each other. In these two modes, the extracellular domains of two subunits move towards each 
other, while those in the third move away from them, and vice versa (Figure 16A). The third 
(mode 3) is a non-degenerate mode that cooperatively induces a 3-fold symmetric 
opening/closing of the three subunits (Figure 16C). Residues at the bottom of the transporter, 
within the membrane, remain rigid in either mode. In view of their mechanistic features, we refer 
to these modes as asymmetric stretching/contraction (mode 1 and 2), and symmetric 
opening/closing (mode 3).  
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In principle, a multitude of modes simultaneously drive the dynamics of the carrier to 
bring HP2 domains together, with the softest modes, including the two shown here, providing the 
largest contributions. We examined the potential change in intersubunit distances at the region of 
interest as the molecule would gradually move along the asymmetric stretching/contraction and 
the symmetric opening/closing modes. As shown in Figure 16B and 16D, the central (bold, red) 
curves display the equilibrium distance between the two approaching subunits, used as reference 
for the residues listed along the abscissa, and the other curves display the distances sampled upon 
collective fluctuations of the trimeric structure along the respective mode.  Residues on HP2b, 
and particularly those at the N-terminal end, tend to come into close proximity, whereas those at 
the C-terminal end remain well-separated, consistent with experimental data in Figure 8.  
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Figure 16. Large collective motions of glutamate transporter trimers predicted by ANM analysis 
(A) and (C) show schematic representations of the asymmetric stretching/contraction mode and the symmetric 
opening/closing mode, respectively, viewed from the EC face. The arrows indicate the direction of motions of the 
three subunits. Intersubunit distances of residues in HP2 and TM8 (based on GltPh Cα atoms between two 
approaching subunits) are significantly altered along the asymmetric stretching/contraction mode (B) and the 
symmetric opening/closing mode (D). The thick red curve refers to the equilibrium distances derived from the X-ray 
structure (PDB ID: 1XFH), and the series of curves above and below refer to different extents of deformation along 
the respective softest mode in positive and negative directions. Human EAAT1 residue numbers are denoted in blue, 
below the abscissa. 
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2.2.7 Crosslinking cysteine substituted mutants of several residues at the N-terminal end 
of TM8 
Interestingly, the analysis of global motions suggests that residues at the N-terminal end of TM8 
and at the loop connecting TM8 and HP2b also come into close proximity (Figure 16B and 
16D). Inspired by this observation, we substituted cysteines for several additional residues at the 
N-terminal end of TM8 and examined the effects of CuPh and/or DTT on transport activity. 
Figure 17A shows the uptake activity for TM8 mutants I469C, A470C and W473C. Consistent 
with the residue proximities predicted by ANM analysis, the transport activity of these mutants is 
significantly impaired by 5 min incubation with 300 μM CuPh, and this inhibition can be 
reversed by DTT. The second order rate constants of crosslinking for I469C, A470C and W473C 
are 6,375 ± 1,344 M-1s-1, 372 ± 116 M-1s-1, and 5,882 ± 2,094 M-1s-1, respectively (Figure 17B). 
Furthermore, I469C and W473C form spontaneous disulfide bonds, because DTT significantly 
increases their uptake activity compared to untreated controls. We also observed dimer band 
signals in I469C and W473C after treatment with the bifunctional crosslinker M8M (Figure 
17C). These data confirm and reinforce the idea that large collective motions of glutamate 
transporters, consistent with the softest modes predicted by ANM analysis, underlie the 
unexpected proximities of residues within the trimer.   
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Figure 17. Crosslinking cysteine substituted mutants of several residues at the N-terminal end of TM8 
 (A) COS7 cells expressing wild type or mutant transporters were treated with 20 mM DTT, or 300 μM CuPh, or 
300 μM CuPh followed by DTT, for 5 min. Uptake assays were performed for 10 min at room temperature using 5 
μM L-[3H] glutamate as substrate. Data are expressed as the percent of uptake activity relative to the CSLS control 
obtained in 2-4 different experiments in triplicate. (B) COS7 cells expressing V449C were treated with different 
concentrations of CuPh for 5 min and uptake activity was measured. IC50 was obtained by fitting data with the 
Michaelis-menten equation and the second order rate constants were also calculated. (C) Oocytes expressing I469C 
or W473C were treated with 1 mM M8M for 5 min. Oocyte membrane samples were collected and subjected to 
western blotting analyses using an EAAT1-specific antibody.   
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2.2.8 Residue V449C in the uncrosslinked subunit is inaccessible for modification after 
crosslinking 
We further examined the functional significance of these large collective motions with regard to 
the transport cycle. A critical step after substrate and co-transported ions bind to the transporter 
is that the transport domain of each subunit moves inward into the cell cytosol, which allows for 
the exposure of the substrate-binding site to the cytoplasm and the release of substrate upon 
opening of the internal gate (50). We hypothesized that the large collective motions might be 
important for the transport domain movement. To test this hypothesis, we focused on the V449C 
mutant, which exhibits a high propensity to crosslink, and asked whether the transport domain in 
the uncrosslinked V449C subunit within the trimer is in an outward- or inward-facing state.  
Earlier studies have shown that V449C can be modified from the extracellular 
environment in Na+-containing solution and modification of V449C completely inhibits substrate 
transport (96). In the inward-facing conformation of GltPh, the equivalent residue of V449 moves 
toward the cytoplasm and is shielded by surrounding TM domains (Figure 18A). We therefore 
first determined whether the V449C cysteine in the uncrosslinked subunit is accessible to thiol-
modifying reagents from the outside. We treated cells expressing V449C with 300 μM CuPh to 
completely crosslink two subunits, and then attempted to react the V449C residue in the 
uncrosslinked subunit with NEM, an irreversible thiol-modifying reagent. As a control, PBS or a 
reversible thiol-modifying reagent, MTSET, was used in place of NEM. After treatment with 
modifying reagents, cells were further treated with 10 mM DTT to reduce disulfide bonds and 
remove reversible modifying groups. If NEM could modify V449C in the uncrosslinked subunit, 
then the uptake activity of the mutant treated with NEM could be reduced by as much as one 
third compared to the PBS or MTSET treated group, assuming that the three subunits operate 
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independently as has been proposed (56, 115). Our results showed that V449C-expressing cells 
treated with CuPh/NEM/DTT exhibit uptake activity comparable to those treated with 
CuPh/PBS/DTT or CuPh/MTSET/DTT (Figure 18B).  
The above data suggest that either the V449C residue in the uncrosslinked subunit is 
inaccessible to NEM or modification in one subunit does not affect the function of the 
transporter trimer. To exclude the latter possibility, we used a biotin-conjugated thiol-modifying 
reagent (maleimide-PEO2-biotin) to react with V449C in the uncrosslinked subunit and then 
allowed the transporter proteins to bind to avidin-conjugated agarose beads. As a control, 
V449C-expressing cells were treated with DTT to reduce spontaneously crosslinked cysteines. 
Although the control group could readily react with the biotin reagent and affinity purified, no 
significant amount of transporter proteins could be obtained in this manner from V449C-
expressing cells treated with CuPh (Figure 18C). Thus, V449C in the uncrosslinked subunit 
cannot be accessed by NEM, indicating that the uncrosslinked subunit exists in an inward-facing 
conformation.  
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Figure 18. Residue V449C in the uncrosslinked subunit is inaccessible for modification after crosslinking 
(A) Location of the equivalent V449 residue (human EAAT1 numbering) in the context of the outward-facing and 
inward-facing GltPh crystal structure (PDB ID:  1XFH and 3KBC). (B) COS7 cells expressing V449C were treated 
for 5 min sequentially with 300 μM CuPh, 1 mM MTSET, 0.5 mM NEM, or 10 mM DTT as indicated. Uptake 
assays were performed for 10 min at room temperature using 5 μM L-[3H] glutamate as substrate. Data are 
represented as the percentage of control in four experiments done in triplicate (n.s., not significant). (C) After 
indicated treatments, surface proteins were biotinylated with maleimide-PEO2-biotin and subjected to western 
blotting analyses. Glutamate transporter proteins were identified using an anti-EAAT1 polyclonal antibody directed 
against the C-terminus. 
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2.2.9 Residue L376C in the uncrosslinked subunit is exposed intracellularly after 
crosslinking of V449C 
The alternating access model predicts that distinct sets of residues are exposed to the intracellular 
environment depending upon whether the carrier faces inward or outward.  An earlier study (92) 
reported that several cysteine substitutions in HP1, TM7, and TM8 of a rat glutamate transporter 
(GLT-1) display increased accessibility to NEM when external Na+ was replaced by K+, a 
condition expected to increase the proportion of inward-facing transporters. We generated single 
cysteine mutations in CSLS background corresponding to the ones identified in GLT-1. As 
expected, the uptake activity of several mutants (A355C, T368C, L376C and V390C) was more 
significantly inhibited after treatment with NEM in a K+- containing solution compared to a Na+- 
containing solution (Figure 19A). Thus, these residues are exposed intracellularly as the 
transport domain moves toward the cytoplasm, which agrees with their positions in the outward-
facing and inward-facing GltPh structures (Figure 19B).  
To determine whether the uncrosslinked subunit in the V449C mutant is inwardly 
oriented, we introduced these cysteine substitutions into the V449C mutant and asked whether 
these conformationally-sensitive residues in the uncrosslinked subunit were accessible 
intracellularly after V449C crosslinking. Cells were treated with 10 mM DTT to reduce 
spontaneous V449C crosslinks, followed by incubation with 300 μM CuPh. As a control, the 
membrane impermeant thiol-modifying reagent, MTSET, was used to protect V449C from 
further modification, and lock transporters in an outward-facing conformation (96). Cells were 
then incubated with the membrane permeant thiol-modifying reagent, NEM. Finally, CuPh-
induced disulfide bonds and MTSET modifications were reversed with 10 mM DTT. We found 
that substrate transport by V449C_L376C is significantly inhibited after sequentially treated with 
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DTT/CuPh/NEM/DTT compared to that treated with DTT/MTSET/NEM/DTT. By contrast, 
other double mutants (V449_A355C, V449C_T368C, and V449C_V390C) show no differences 
in substrate transport between these two treatments (Figure 19C). We also used a membrane 
permeable biotin-conjugated thiol-modifying reagent (maleimide-biotin) to react with the 
cysteines in uncrosslinked subunits and then allowed the transporters to bind to avidin-
conjugated agarose beads. Significant amounts of V449C_L376 are affinity-purified after 
crosslinking, but not the mutant carrier V449C_T368C (Figure 19D). Interestingly, L376C is 
most proximal to the cytoplasm among the residues tested, and would be the first exposed to the 
IC environment as the transport domain moves down (Figure 19B). These data confirm that the 
transport domain in the uncrosslinked subunit is inwardly oriented when the two remaining 
subunits are crosslinked extracellularly. 
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Figure 19. Residue L376C in the uncrosslinked subunit is exposed intracellularly after crosslinking of V449C 
(A) COS7 cells expressing wild type or mutant transporters were treated with 0.25 mM NEM, except for the mutant 
L352C where 1 mM NEM was used, for 5 min in Na+- or K+-containing solution. Uptake assays were carried out for 
10 min at room temperature using 5 μM L-[3H] glutamate as substrate. The remaining uptake activity was presented 
after normalizing to untreated controls in respective cation condition. (B) Location of the equivalent residues (A355, 
T368, L376 and V390, human EAAT1 numbering) in the context of the outward-facing and inward-facing GltPh 
crystal structure (PDB ID:  1XFH and 3KBC). (C) COS7 cells expressing wild type or mutant transporters were 
treated with 10 mM DTT, 1 mM MTSET, 0.5 mM NEM or 300 μM CuPh for 5 min as indicated before assaying for 
transport activity (*, p<0.05). (D) After indicated treatments, surface proteins were biotinylated with maleimide-
biotin and subjected to western blotting analyses. Glutamate transporter proteins were identified using an anti-
EAAT1 polyclonal antibody directed against the C-terminus. 
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2.2.10 Glutamate transporters favor stepwise transitions between outward-facing and 
inward-facing states 
The above experimental data suggest that the glutamate transporter trimer transits through a state 
where two subunits are outward-facing and approach each other while the third moves inward. 
However, the available crystal structures of GltPh show that all three subunits assume the same 
conformation, facing either outward or inward (PDB ID: 1XFH and 3KBC). Whether the 
conformation state we observed is an on-pathway structure towards achieving the fully-inward 
conformation or a consequence of intersubunit crosslinks, is not known. In other words, whether 
glutamate transporters tend to undergo an all-or-none transition (of all three subunits) between 
inward-facing and outward-facing states or a stepwise transition, to enable alternating access, is 
yet to be understood.  
To address this question, we examined the distribution of ANM modes that contribute to 
the structural transition between different states. Many studies have compared the structural 
change between two structurally resolved forms (e.g., open and closed states) of a given protein, 
with the soft modes predicted by ANM analysis for one of the conformers (116). The difference 
between any pair of structures is quantitatively described by a 3N-dimensional deformation 
vector d, evaluated by overlaying the two structures to remove rigid-body translations and 
rotations. The deformation vector d is then compared with the eigenvectors of individual 
predicted ANM modes and the correlation cosines squared represents the contribution of each 
ANM modes to the overall structural change between two endpoints. In principle, because the 
eigenvectors form a complete orthonormal basis set, the correlation cosines squared sum up to 
unity 1. The summation (cumulative overlap) is performed over the subset of modes of interest, 
usually starting from the lowest-lying modes. These studies show that a very small subset of soft 
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modes (if not the top 1–3) yields a cumulative overlap of 0.80 ± 0.15 with experimentally 
observed structural changes (117). Cumulative overlap also provides a means to compare the 
ease of different transitions because soft modes are by definition the most energetically favorable 
modes, and undertaking a structural change along softer modes is more likely than another which 
involves higher-frequency (or stiffer) modes. 
We consider four possible states of GltPh, with the numbers of outward/inward- facing 
subunits being 3/0, 2/1, 1/2 and 0/3, as illustrated in Figure 20A. The states 3/0 and 0/3 are the 
experimentally resolved 3-fold symmetric structures, and 2/1 and 1/2 are models reconstructed 
by assembling the outward-facing and inward-facing subunits upon superimposition of their 
trimerization domains. Figure 20B provides a schematic view of possible transitions between 
these states. The left vertical path (designated as 4 and 4’ for the clockwise and counterclockwise 
steps, respectively) refers to an all-or-none transition, and the other three steps (1-3 and 1’-3’) 
refer to the stepwise transitions, between the two experimentally known structures. We examined 
cumulative overlaps between ANM-predicted low frequency modes and the structural change at 
each step (Figure 20C and 20D). Panel C compares the all-or-none transition from the outward-
facing state to the inward-facing state (blue curve) to the stepwise transitions in the same 
direction (red, green and black curves).  Each of the three transitions that involve intermediate 
states is achieved by fewer number of low frequency modes (i.e. energetically more favorable) 
and is thus ‘easier’ than the all-or-none transition. A similar pattern is observed for the reverse 
transition as well (Figure 20D). These results support the notion that the conformation state we 
observed is a physically viable step towards achieving the fully-inward conformation.  
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Figure 20. Cumulative overlap of ANM modes and transitions between pairs of conformations 
(A) Cartoon representation of the four structures used for transport domain transitions. The All Outward (3/0) and 
the All Inward (0/3) conformations represent the 1XFH and 3KBC structures, respectively. In the Two Outward 
structure (2/1), one subunit faces inward (cyan), while in the Two Inward structure (1/2), two subunits face inward 
(green and cyan). (B) A schematic representation of the passages between different conformations. (C) and (D) 
Cumulative overlap of the ANM modes with the deformation vector between pairs of conformations indicated by 
the labels on the paths.  The control curves refer to the case of randomly oriented modes that contribute equally to 
conformational transitions.  
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2.2.11 Impact of crosslinking on the substrate-gated anion flux 
In addition to transporting substrates, which generate two positive charges into the cell per 
transport cycle, glutamate transporters also function as a substrate-activated anion channel. Thus, 
glutamate elicited currents are comprised of a substrate-coupled component that dominates at 
membrane potential of -100 mV, and a substrate-activated uncoupled anion component that 
dominates at +60 mV. To examine the impact of crosslinking on the anion channel activity, we 
focused on V449C, which displays minimal transport activity after crosslinking in oocytes, thus 
no substrate-coupled currents. In Cl- containing solution, the control CSLS transporter exhibits 
similar glutamate-elicited currents before and after CuPh treatment. When the mutant carrier 
V449C was treated with 300 µM CuPh, substrate-elicited currents at -100 mV are significantly 
decreased and the currents reverse near the oocyte chloride reversal potential. Further incubation 
with 20 mM DTT increases the amplitude of currents at -100 mV induced by glutamate and the 
reversal potential becomes more positive compared to the untreated control, as the spontaneous 
crosslinks are reduced (Figure 21A). We also substituted the more permeable anion NO3- for Cl-, 
and observed comparable glutamate-elicited NO3- currents in V449C-espressing oocytes after 
DTT or CuPh treatment (Figure 21B). These results suggest that, remarkably, glutamate can still 
activate the anion conductance even when two subunits are constrained by crosslinking, and 
substrate transport no longer occurs.  
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Figure 21. V449C retains substrate-activated anion conductance after crosslinking 
Using a two electrode voltage clamp, currents from oocytes expressing CSLS or V449C were recorded in 
Cl--containing solution (A), and in a solution in which Cl- was replaced by NO3- (B).  Recordings were 
made before (filled square) and after (filled triangle) application of 300 µM CuPh (5 min), as well as after 
additional treatment with 20 mM DTT (5 min, open circle). Currents obtained in the absence of glutamate 
were subtracted from those elicited by 1 mM L-glutamate. Currents were normalized to the control 
currents at -100 mV. 
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2.3 DISCUSSION 
The present study was driven by the observation that single cysteine substitutions for residues of 
HP2b in the human glutamate transporter EAAT1, form spontaneous and/or CuPh-catalyzed 
intersubunit crosslinks. Substrate translocation activity is abolished in the mutant transporters as 
a consequence of crosslinking, but the substrate-activated anion conductance associated with the 
carrier is retained. Evidence for the close proximity of two inter-subunit cysteines and their 
capacity to form disulfide bonds comes from the following observations: first, although the 
mutants V449C and I453C fractionate as monomers by non-reducing SDS-PAGE before CuPh 
treatment, they migrate as both monomers and dimers after CuPh treatment (Figure 9); second, 
the addition of the reducing reagent, DTT, reverses both the transport inhibition and the 
formation of crosslinked dimers (Figure 6 and 9); and third, the presence of cadmium ions in the 
uptake solution also inhibits the transport activity of V449C and I453C (Figure 6). This latter 
observation is consistent with the idea that the two cysteines are near each other to coordinate 
Cd2+, although it should be noted that Cd2+ can bind to the thiol-group of a single cysteine 
residue. Previous studies have shown that modification of cysteine substituted residues in HP2b 
region by other thiol-modifying reagents such as MTSET significantly inhibits substrate 
transport (90). Thus, the inhibition of substrate transport by Cd2+ in the mutant carriers V449C 
and I453C could be a consequence of interaction between Cd2+ and single cysteines instead of 
the coordination of Cd2+ by two adjacent cysteines. At present, we are unable to rule out this 
possibility and the Cd2+ experiment can only be viewed as complementary evidence to support 
the proximity of substituted cysteines between two adjacent subunits.  
We noticed that the mutant I453C shows a stronger dimer band signal compared to 
V449C, although transport by I453C is less dramatically inhibited after crosslinking (Figure 9). 
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This inconsistency would be explained by either the complete inhibition of substrate transport by 
CuPh in V449C is partially due to the oxidization of single cysteines, or alternatively, by the 
instability of disulfide bonds during the biochemical assays.  It is suggested that CuPh treatment, 
under some cases, oxidizes cysteine residues to sulfinic and sulfonic acids (118). However, these 
high oxidation states of cysteine cannot be reduced by DTT and in our study, the functional 
inhibition of the cysteine substituted mutants is completely reversed by DTT (Figure 8). These 
results suggest that the complete inhibition of substrate transport in V449C is a result of CuPh-
catalyzed disulfide bond formation. Additional experiments revealed that the V449C disulfide 
bonds are less stable during oocyte membrane preparation, because we observed a similar 
inhibition of uptake, but a substantially more prominent V449C dimer species using a 
bifunctional crosslinking reagent instead of CuPh (Figure 10).  
We further excluded several other scenarios in which CuPh-catalyzed crosslinks might 
occur in single cysteine substituted glutamate transporters. First, we considered the possibility 
that disulfide bonds form between a transporter subunit and an unknown protein of similar 
molecular mass. Because mutant glutamate transporters are overexpressed in both the COS7 cell 
and Xenopus oocyte expression systems, the unknown protein would need to be a membrane 
protein expressed abundantly in both systems in order to crosslink one-to-one with transporter 
subunits, making this scenario less attractive. One way to experimentally exclude this possibility 
is to coexpress two different tagged mutant transporters (e.g. HA-V449C and myc-V449C) and 
see if antibody against one tag could pull down the other after crosslinking. This strategy is 
problematic because we and others have shown that glutamate transporters tend to aggregate 
during biochemical assays even without crosslinking (43, 77). Instead, we took advantage of size 
difference between the untagged V449C and an N-terminus GFP-tagged V449C. When 
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coexpressed, we observed crosslinked bands corresponding to three dimer species 
(V449C/V449C, V449C/GFP-V449C, and GFP-V449C/GFP-V449C). If crosslinking the 
subunits to an unknown protein, we would expect to see two crosslinked species, one between 
V449C and the unknown protein, and the other between GFP-V449C and the unknown protein 
(Figure 11). These results suggest that crosslinks in V449C take place between two transporter 
subunits. Second, we considered the possibility that disulfide bonds form between two 
transporter subunits of adjacent trimers. If this occurred, we would expect to see at least hexamer 
species (crosslinking of two transporter trimers) when separated by BN-PAGE, which preserves 
oligomeric structures of proteins. Our results showed that both V449C and I453C migrate as 
trimer species in blue native gels and no higher molecular weight bands are observed after CuPh 
treatment, suggesting that disulfide bonds form between two transporter subunit in a single 
trimer (Figure 12). These results further support that crosslinking does not occur between a 
transporter subunit and an unknown protein. In addition, we have successfully constructed a 
functional concatenated glutamate transporter trimer that physically links the three transporter 
subunits with flexible peptide linkers. This construct allows the introduction of either one or two 
V449C subunits in the trimer. We found that CuPh inhibits the uptake activity of the 
concatenated carrier when it contains two V449C subunits, but not when it contains only one 
V449C subunit (Data not shown, and see chapter 4 in this dissertation for concatemer 
information). Taken together, we concluded that several single cysteine substitutions for residues 
of HP2b form spontaneous or CuPh-induced disulfide bonds between two transporter subunits of 
a single trimer.  
Based on the outward-facing crystal structure of the GltPh trimer, the distances between 
the crosslinkable residues of HP2b in adjacent subunits are significantly greater than that 
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required to form disulfide bonds, suggesting that domains within the glutamate transporter trimer 
are capable of large-scale movements in the absence of substrate. In collaboration with Dr. Ivet 
Bahar’s group in the Department of Computational and Systems Biology at the University of 
Pittsburgh, we explored the dynamics of glutamate transporters using computational simulations. 
Our molecular dynamics (MD) simulations revealed that the HP2 loop possesses an intrinsic, 
structure-induced ability to ‘open up’ and expose the substrate binding site to the aqueous basin, 
thus acting as an extracellular gate (Figure 15). These results agree with the TBOA-bound 
crystal structure of GltPh, which revealed the displacement of HP2 from the substrate binding site 
(49). However, detailed analysis of the MD trajectory suggest that such local motions fall short 
of bringing two HP2b helices sufficiently close to form crosslinks. ANM analysis, on the other 
hand, predicts two major types of large collective motions to be energetically more favorable: an 
asymmetric stretching/contraction and a symmetric opening/closing mode. Residues in the EC 
domains of adjacent subunits approach each other in either modes, and thus enable the formation 
of intersubunit disulfide bridges (Figure 16). By contrast, residues at the bottom of the 
transporter, within the membrane, remain rigid, in agreement with earlier findings (119). ANM 
calculations also suggest that residues at the N-terminal end of TM8 between two subunits tend 
to come into close proximity. This prediction was confirmed experimentally by crosslinking of 
single cysteine substituted mutants in this region (Figure 17). Our current study thus underscores 
the existence of large-scale, intrinsic movements of subunits in glutamate transporters shown 
experimentally and predicted computationally. 
 Because global motions of proteins are usually intrinsic and driven by their tertiary and 
quaternary structures, the presence of substrate is unlikely to disrupt such collective movements 
(120). Experiments to confirm this argument are complicated by the fact that substrate or 
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inhibitors may influence conformational changes other than large collective motions that also 
contribute to observed crosslinks. We noted that the ability of cysteine substituted mutants in 
HP2b to form disulfide bonds, parallels their modification rates by sulfhydryl-reactive reagents 
reported previously (90). In particular, mutants L448C, V449C, V452C and I453C exhibit fast 
rates of modification whereas M451C, V454C, L455C, T456C and V458C have much slower 
rates. Similarly, transporters with mutations near the HP2 loop, L448C, V449C, V452C, I453C, 
V454C, readily form crosslinks after CuPh treatment. Furthermore, the mutant carriers L448C 
and V449C form spontaneous crosslinks (Figure 8). These results suggest that local 
rearrangements of the HP2 region may also contribute to bringing residues in HP2b between two 
subunits into close proximity. Nevertheless, there is growing evidence for the functional 
relevance of the global movements predicted by coarse-grained network models in substrate-free 
forms (120-121). Although the crosslinking captured in the current study occurs in non-
transporting carriers, the large collective motions that enable crosslinking will also take place 
and have functional impact in actively-transporting carriers. Supporting this idea, the inward 
movement of the transport domain, which was proposed based on crosslinking two introduced 
cysteines in TM2 and HP2, readily occurs in the absence of Na+ and substrate, and has been 
suggested to be a critical step of the transport cycle (50, 94).  
In contrast to our report, Koch et al. proposed that small-scale molecular motions around 
the substrate binding site are sufficient to accomplish glutamate uptake in human glutamate 
transporters (93). Their findings can be easily reconciled with our observations. Koch et al. used 
FRET assays as a means to compare the relative positions of extracellularly exposed EAAT 
residue pairs in a choline-substituted solution in the absence of substrate (non-transporting state) 
to those in a Na+-containing solution with 1 mM glutamate (transporting state). No significant 
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changes in FRET efficiencies were observed between the two conditions. FRET assays 
determine the distance of residue pairs averaged from a population of proteins and over the 
experimental timeframe of signal acquisition when proteins undergo a broad range of 
conformational fluctuations. Because the large collective motions proposed in our study are 
likely to occur in both substrate-free and actively-translocating transporters, the average 
distances measured by FRET assays under the two conditions would be comparable. 
In fact, such collective motions are essential to the transition of the transporter from 
outward-facing to inward-facing state and vice versa, during the completion of the transport 
cycle. After crosslinking of V449C, the uncrosslinked subunit assumes an inwardly-facing 
orientation, as evidenced by the inaccessibility of the V449C cysteine from the extracellular 
environment in the uncrosslinked subunit (Figure 18) and the exposure of the L376C cysteine to 
the cytoplasm (Figure 19). Thus, crosslinking captures a conformational state during the 
transport cycle in which two subunits of the trimer approach each other in the outward-facing 
state while the transport domain of the third subunit moves inward. These results suggest that the 
large changes in structure observed in our study can be functionally linked to the inward 
movement of the transport domain, a critical step for substrate transport.  
ANM calculations confirm that a stepwise transition of individual transport domain is a 
more viable mechanism to enable alternating access of the transporter to the EC and IC regions, 
compared to an all-or-none transition of all three subunits. Several studies introduced mutations 
to alter the function of one or more subunits, determined their impact on overall function, and 
concluded that each subunit functions independently during substrate transport (56, 115, 122). 
Yet it is still debatable whether allosteric interactions modulate the anion channel function (115, 
123). Although our results generally agree with the idea that each subunit can function 
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independently (the transport domain moves individually), the experiments presented here, which 
disrupt the collective motions of the trimer, reveal a higher order cooperative nature of subunit-
subunit interactions. Such cooperativity would not be captured in earlier studies because the 
mutations used would have no effect on global motions.  In chapter 4, we will further explore the 
subunit interactions of transport functions using a concatenated glutamate transporter trimer.  
Finally, although the V449C mutant is unable to transport substrates after crosslinking, it 
retains substrate-elicited anion currents. Since the uncrosslinked subunit in V449C is restricted in 
an inward-oriented conformation and is likely not accessed by substrate, anions have to flow 
through the two crosslinked subunits. The apparent Km for glutamate activation of the anion 
conductance is reduced after V449C crosslinking (Km = 8.35 ± 1.02 µM for V449/CuPh vs. Km = 
30.98 ± 3.05 µM for V449C/DTT), consistent with the idea that HP2 remains open in the two 
crosslinked subunits. Similarly, Seal et al. showed that modification of V449C also abolishes 
substrate transport, but increases the substrate-gated anion conductance (96). It is currently 
debatable which step in the substrate transport cycle conducts anion currents, but our results 
support the idea of a conducting state at an early step of the transport cycle after substrate 
binding. Further studies will shed light on how the substrate transport is linked to the anion 
conduction (See chapter 3) and whether the alternating access mechanism is facilitated by 
visiting intermediate states with different conformations of the subunits (i.e. inward- and 
outward-facing). 
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3.0  A CONSERVED POSITIVE CHARGE IN TM7: A KEY PLAYER IN 
GLUTAMATE TRANSPORTER DUAL FUNCTIONS 
3.1 INTRODUCTION 
In Chapter 2, we showed that after crosslinking of V449C, substrate cannot be transported into 
the cell, but is still able to elicit anion currents. We suggested that the substrate-activated anion 
currents are generated by the two crosslinked subunits which have a more restricted capacity to 
undergo conformational changes. Thus, a conducting state occurs at an early step after substrate 
binds to the transporter and does not require substantial structural rearrangement. Supporting this 
idea, studies have shown that the substrate-activated anion currents can still occur at 4°C when 
substrate transport is abolished (29).  
In addition to this anion conducting state activated by substrate at the early step(s) of the 
transport cycle, glutamate transporters allow anions to traverse the cell membrane in the absence 
of the substrate (33). This current requires extracellular Na+ and is referred to as the Na+-
activated anion leak current. Other anion conducting states during the transport cycle have also 
been suggested (124-125). Because of technical challenges to isolate individual steps of the 
transport cycle following glutamate binding, the assignment of the anion conducting states was 
achieved by chemical-kinetic simulations that model recorded transport and anion currents. In 
addition, by using fast application of glutamate to measure the pre-steady state of the transport 
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current and the anion current, these studies show that both pre-steady state currents rise quickly 
after glutamate application and decay to a steady state, suggesting that the substrate transport 
process is closely linked to the substrate-gated anion conductance (124, 126). However, despite 
gains in knowledge of transporter domains and conformational changes required for substrate 
transport, limited evidence exists to show how the anion channel is activated by Na+ and 
substrate, and how anion channel activation and substrate transport are coordinated.   
Establishing the anion permeation pathway will also facilitate our understanding of the 
anion channel function. It is suggested that anions permeate glutamate transporters through a 
pathway different from the substrate. As we have observed for the crosslinked V449C, three 
separate studies showed that modification of cysteine substituted residues in HP2 disrupts 
glutamate transport, but allows glutamate binding and activation of the anion channel (96-98). 
Mutants that abolish substrate-activated anion current without interfering with substrate transport 
have yet to be identified. Ryan et al. reported that mutations of several polar or charged residues 
in TM2 influence various properties of the anion channel, but not the transport of substrate (95). 
In particular, residue S103 in human EAAT1 is implicated in forming part of the selectivity filter 
of the anion channel, because glutamate-activated anion current in the mutant carrier S103V 
displays an altered rank order of relative permeability to different anions (95). In addition, one 
mutant, D112A in human EAAT1 has a greatly increased Na+-activated anion leak currents, but 
decreased substrate-activated anion currents. Residue D112 was proposed to serve as a gating 
residue for the channel (95).  
Based on the crystal structure of GltPh (PDB ID: 1XFH), we hypothesized that residues in 
TM7 might be involved in the anion channel function because TM7 is spatially very close to 
TM2, and is also a critical domain for binding Na+ and substrate. While we were testing this 
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hypothesis, Huang et al. identified additional residues in TM7 and TM5 that are involved in 
mediating the leak and substrate-activated anion current (99). In this study, they investigated 
charged residues within 5Å from residues S103 and D112 in EAAT1 based on the GltPh 
structure, which could influence the conformations of these two residues. Their results showed 
that residues D272 in TM5 and K384/R385 in TM7 display changed amplitudes of leak 
conductance and substrate-activated anion conductance when mutated to neutral or oppositely 
charged amino acids (99). Thus, TM2, 5 and 7 appear to contribute to the formation of the anion 
permeation pathway. It should be noted that both this study and one by Ryan et al. directly 
compare uptake activities and current amplitudes between wild type and mutant transporters, 
without considering the surface expression of individual carriers. Most of their data can also be 
attributed to the altered surface expression by the mutations. Thus, more rigorous 
characterization of these mutant carriers or identification of new mutants around this region may 
further elucidate the molecular determinants of the anion channel function.  
In the present study, we identified a conserved residue, R388 in TM7 of human EAAT1 
that is involved in both substrate transport and anion conduction. Neutralizing R388 with the 
amino acid alanine significantly impairs uptake activity compared to wild type transporters, and 
increases the Na+-activated anion leak current. Reversing the positive charge of R388 with either 
amino acid aspartate or glutamate results in accumulation of substrate through an electroneutral 
process. More interestingly, the mutant carriers R388D and R388E display no substrate-activated 
anion current. A similar phenotype is also observed in an equivalent mutant of rat EAAT4, 
rEAAT4 R410E. Detailed characterization of the mutant transporter R388D show that this 
carrier predominantly exists in the anion leak state, indicating the gating mechanism of substrate-
activated anion current is disrupted. Finally, we demonstrate that the transport domain of the 
 80 
mutant carrier R388D spends a longer time in the inward-facing orientation in the absence of 
substrate. These results not only suggest that R388 is an important element in the functional 
coupling between substrate transport and the anion channel activity, but also illuminate the role 
of the inward transport domain movement in anion permeation.  
3.2 RESULTS 
3.2.1 Residue R388 plays an important role in substrate transport 
Residue R388 is highly conserved in mammalian glutamate transporters (Figure 22A) and is one 
helix turn away from residues K384 and R385 in TM7. To determine the importance of this 
residue in transporter functions, we first neutralized R388 by replacing arginine with a small 
non-polar amino acid, alanine, and assessed its transport activity relative to the wild type 
transporter. It should be noted that the initial EAAT1 mutations in this chapter were generated 
within a cysteineless version of the transporter because it enables the use of cysteine accessibility 
assays to probe the conformation of the transport domain (see section 3.2.6). Previous studies 
have shown that the activity of the CSLS carrier is very similar to the wild type EAAT1 (41), 
however, we have also reconfirmed critical observations using mutant carriers generated within 
the wild type EAAT1 background. 
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Figure 22. Neutralizing the charge of residue R388 with amino acid alanine impairs substrate transport 
(A) Sequence alignment of the highly conserved TM7 region. R388 is highlighted with red box, and residues K384 
and R385 are indicated with inverted triangles. (B) Wild type human EAAT1 transporters and mutant carriers 
(R388K or R388A) were expressed in Xenopus oocytes. Uptake assays were carried out at room temperature using 
100 μM L-[3H] glutamate as substrate for 15 min and data are normalized to wild type transporters.  (C) I-V relation 
of 100 μM L-glutamate elicited current recorded in Cl- solution using two-electrode voltage clamp for oocytes 
expressing wild type transporters (filled circle), R388K (filled square), R388A (filled triangle) or water-injected 
oocytes (open diamond). (D) Representative surface biotinlyation assays of oocytes expressing wild type and mutant 
transporters. Glutamate transporter proteins were identified using an anti-EAAT1 polyclonal antibody directed 
against the C-terminus. 
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Using radioactive glutamate uptake assays, we found that the transport activity of R388A 
is reduced to ~20% of the wild type transporters (Figure 22B). We also recorded substrate-
elicited currents in Cl- solution using two-electrode voltage clamp recordings (the current in the 
absence of substrate was subtracted from that in the presence of substrate). Because the influx of 
one glutamate molecule is associated with the inward movement of two positive charges and 
glutamate transporters also possess an anion channel function, the recorded current is comprised 
of substrate-coupled current and substrate-activated uncoupled anion current. At a membrane 
potential of -100 mV, the majority of current arises from the substrate-coupled transport current 
with its amplitude being proportional to the substrate transport activity. Consistent with the 
results obtained with uptake assays, application of 100 µM glutamate to the R388A mutant 
carrier generates a significantly decreased inward current at -100mV compared to wild type 
transporters (Figure 22B and 22C), although the voltage dependence of glutamate-elicited 
currents remains unchanged (Figure 22C). The decreased substrate transport activity of R388A 
cannot be explained by reduced surface expressions because cell surface biotinylation assays 
show that R388A has a comparable surface level as wild type transporters (Figure 22D). 
The mutant carrier R388K, which conserves the positive charge, also shows a reduced 
substrate transport activity compared to the wild type EAAT1, but is less impaired than R388A 
(Figure 22 B-D). In contrast, when we replace arginine with the negatively charged amino acid 
aspartate or glutamate, the mutant carriers R388D and R388E accumulate 10%-15% radioactive 
substrates compared to the wild type EAAT1 (Figure 23A). R388D and R388E also express less 
at the cell surface, which may contribute to their reduced transport activity. To our surprise, even 
though these two mutant carriers accumulate substantial amounts of radioactive substrate, no 
substrate-coupled transport currents at -100 mV are observed (Figure 23B). These data suggest 
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that R388D and R388E uptake substrate through an electroneutral process. Thus, arginine at 
position 388 in human EAAT1 plays an important role in substrate transport. Mutating arginine 
to alanine significantly decreases substrate transport activity and reversing the positive charge 
with either aspartate or glutamate results in accumulation of substrate through an electroneutral 
process. 
 
 
 
 
 
 
 
 
 
Figure 23. The mutant carriers R388D and R388E accumulate substrate through an electroneutral process 
(A) Wild type human EAAT1 transporters and mutant carriers (R388D or R388E) were expressed in Xenopus 
oocytes. Uptake assays were carried out at room temperature using 100 μM L-[3H] glutamate as substrate for 15 min 
and data are normalized to wild type transporters (Note the segmented y-axis). Representative surface expression of 
wild type and mutant transporters is shown in the boxed inset.  (B) I-V relation of 100 μM L-glutamate elicited 
current recorded in Cl- solution using two-electrode voltage clamp for oocytes expressing wild type EAAT1 
transporters (filled circle), R388D (open square), R388E (inverted open triangle) or water-injected oocytes (open 
diamond). 
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3.2.2 Residue R388 is critical for the anion channel function  
To determine the role of residue R388 on the anion channel function, we substituted NO3-, a 
more permeant anion for extracellular Cl- to increase the amplitude of anion currents. Under this 
condition, the recorded current is largely contributed by anions flowing through the transporter 
and the substrate-coupled current is negligible. Because anion conductance associated with 
glutamate transporters can be activated by Na+ alone (in the absence of substrate, termed as        
I-Glutamate in the following sections) and is significantly increased with the addition of substrate (in 
the presence of substrate, as I+Glutamate), we directly plotted I-V curves of recorded currents 
without subtracting I-Glutamate from I+Glutamate as we did in previous sections. Such analysis allows 
assessment of the magnitude of the Na+-activated anion leak current and also enables a quick 
determination of whether the transporter is expressed on the cell surface. In addition, the ratio of 
I+Glutamate to I-Glutamate (usually at positive membrane potentials) is not dramatically influenced by 
the surface expression level of transporter proteins and can be used to assess any selective 
changes in either the anion leak current or the substrate-activated anion current. 
Oocytes expressing wild type or mutant transporters R388A and R388K display 
significantly larger I-Glutamate compared to water-injected oocytes, indicating that transporter 
proteins are expressed on the cell surface and that leak anions flow through (Figure 24A-C, 
black circle vs. open diamond). The mutant carrier R388A in general has larger current in the 
absence of glutamate (I-Glutamate) than the wild type EAAT1 transporter or the mutant carrier 
R388K, but less additional current elicited by glutamate. The ratio of I+Glutamate to I-Glutamate at +60 
mV for R388A is 1.395 ± 0.032, and is significantly smaller than that of the wild type EAAT1 
transporter (2.571 ± 0.1) and the mutant carrier R388K (2.511 ± 0.09) (Figure 24D). These 
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results suggest that either the Na+-activated anion leak current or the substrate-activated anion 
current is altered in the mutant carrier R388A. 
 
 
Figure 24. Neutralizing the charge of Residue R388 alters the anion channel function of EAAT1 
Oocytes expressing wild type transporters (A), R388A (B) or R388K (C) were recorded in the absence and presence 
of 1 mM L-glutamate using NO3- as external anions in replacement of Cl-. Endogenous currents were also included 
by recording water-injected oocytes (open diamond). The ratio of current in the presence of substrates (I+Glutamate, 
red triangle) relative to that in the absence of substrate (I-Glutamate, black circle) at positive potentials in (A-C) was 
calculated and shown in (D). 
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Oocytes expressing the mutant carriers R388D and R388E also display larger I-Glutamate 
compared to water-injected oocytes (Figure 25, black circle vs. open diamond). This current can 
be inhibited by 400 µM TBOA, confirming that the current arises from the anion leak 
conductance through the mutant carriers (Figure 25, inverted triangle). Interestingly, current 
recorded in the presence of 1 mM glutamate (I+Glutamate) superimposes on the top of that in the 
absence of glutamate (I-Glutamate) (Figure 25, red triangle vs. black circle), suggesting that 
substrate no longer elicits additional anion currents in either mutant carrier. Thus, R388 is also 
critical for the anion channel function. Mutating arginine to alanine significantly decreases the 
ratio of current in the presence of substrate (I+Glutamate) to that in the absence of substrate (I-
Glutamate), and reversing the positive charge with either aspartate or glutamate abolishes the 
substrate-activated anion current. 
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Figure 25. Substrate no longer elicits additional currents in the negatively-charged R388 mutants 
The mutant carriers R388D (A) and R388E (B) were expressed in Xenopus oocytes. Currents in the absence (black 
circle) and presence of 1 mM L-glutamate (red triangle) were recorded using NO3- as external anions. Currents in 
the presence of 400 μM TBOA was shown as inverted triangle and endogenous currents were also included by 
recording water-injected oocytes (open diamond). 
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3.2.3 The mutant carrier R388D predominantly exists in the anion leak state 
The inability of L-glutamate or D-aspartate (data not shown) to elicit additional currents in the 
mutant carriers R388D and R388E suggests that the link between glutamate binding and the 
gating mechanism may be disrupted, and thus the mutant carriers spend more time in the anion 
leak state (I-Glutamate). Alternatively, the mutated carrier may exist in a conformation in which the 
channel reaches the I+Glutamate state even in the absence of substrate. To resolve these possibilities, 
we focused on unique properties that distinguish the substrate-gated and anion leak conductance. 
It has been shown that substrate alters the relative permeability to different anions in EAAT2 and 
EAAT4. In other words, the relative conductance of various anions differs between the I+Glutamate 
and I-Glutamate states (127). We therefore determined the relative permeability of anions for the 
I+Glutamate and I-Glutamate states by measuring the ratio of macroscopic currents at +60 mV in one 
anion relative to another. 
. 
In oocytes expressing wild type EAAT1, the relative conductance of NO3-/Cl- and SCN-
/Cl- is 1.91 ± 0.11 and 6.90 ± 0.51 in the I-Glutamate state, respectively. Application of 1 mM 
glutamate (the I+Glutamate state) increases the respective relative conductance of NO3-/Cl- and SCN-
/Cl- to 4.62 ± 0.42 and 23.96 ± 1.78 (Figure 26A and 26B). Because glutamate cannot elicit 
additional currents in the mutant carrier R383D, the relative conductance in the I-Glutamate state 
would be the same as that in the I+Glutamate state. Indeed, our results showed that the relative 
conductance of NO3-/Cl- and SCN-/Cl- measured for R388D is 1.89 ± 0.26 and 6.81 ± 1.0 in the I-
Glutamate state, and is 1.91 ± 0.26 and 6.90 ± 1.13 in the I+Glutamate state, respectively. These ratios 
are remarkably similar to those of the I-Glutamate state of the wild type EAAT1 transporter (Figure 
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26B), suggesting that the mutant carrier R388D predominantly exists in the anion leak state and 
the gating mechanism by glutamate might be impaired with the introduced negative charge.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. The mutant carrier R388D predominantly exists in the anion leak state 
(A) Wild type EAAT1 and the mutant carrier R388D were expressed in Xenopus oocytes. Currents in the absence 
(filled circle) and presence of substrate (open circle) were recorded in Cl-, NO3- or SCN- containing solutions. (B) 
Ratio of the current measured at +60 mV with different permeating anions (NO3- to Cl- and SCN- to Cl-) for both 
wild type and mutant carriers. Black dashed lines represent the ratio of currents recorded in the absence of substrate 
and red dashed lines represent the ratio of currents recorded in the presence of substrate for the wild type EAAT1 
transporter.   *, p<0.05.   
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3.2.4 The corresponding mutant carrier R410E of rat EAAT4 predominantly exists in the 
anion leak state  
Because the arginine residue is highly conserved in all of the mammalian glutamate transporters, 
we replaced the equivalent arginine residue in rat EAAT4 (rEAAT4) by the amino acid 
glutamate and asked if the mutation also abolishes the glutamate-gated anion channel activity. 
Just as we observed with R388D and R388E in EAAT1, no additional macroscopic anion current 
is observed upon glutamate application in oocytes expressing the rEAAT4 R410E mutant carrier, 
while glutamate elicits a large NO3- current in those expressing the wild type rEAAT4 
transporter (Figure 27A). rEAAT4 R410E transporter proteins are expressed on the cell surface 
because the current recorded in the absence of substrate (I-Glutamate) is significantly larger than that 
obtained in water-injected oocytes, as a result of the anion leak conductance through the 
expressed transporters (Figure 27A). Glutamate increases the relative conductance of NO3-/Cl- 
from 1.77 ± 0.11 in the I-Glutamate state to 6.31 ± 0.65 in the I+Glutamate state for the wild type 
rEAAT4 transporter, and increases the relative conductance of SCN-/Cl- from 11.59 ± 1.42 in the 
I-Glutamate state to 24.26 ± 2.13 in the I+Glutamate state.  The mutant carrier rEAAT4 R410E has 
similar relative conductance as the wild type rEAAT4 in the I-Glutamate state (Figure 27B). The 
relative conductance of NO3-/Cl- is 2.94 ± 0.14 in the I-Glutamate state and 2.93 ± 0.15 in the 
I+Glutamate state,  and that of SCN-/Cl- is 10.62 ± 0.84 in the I-Glutamate state to 10.87 ± 0.78 in the 
I+Glutamate state. These results indicate that with both isoforms (human EAAT1 and rEAAT4), 
mutating the arginine to a negatively charged amino acid prevents glutamate from gating the 
anion channel and therefore glutamate is no longer able to increase anion permeation. 
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Figure 27. The mutant carrier rEAAT4 R410E predominantly exists in the anion leak state 
(A) Currents in the absence (black circle) and presence of 1 mM L-glutamate (red triangle) were recorded using 
NO3- as external anions. Endogenous currents were also included by recording water-injected oocytes (open 
diamond). (B) Currents were recorded in Cl-, NO3- or SCN- containing solutions. Ratio of the current measured at 
+60 mV with different permeating anions (NO3- to Cl- and SCN- to Cl-) for both wild type and mutant carriers. Black 
dash lines represent the ratio of currents recorded in the absence of substrate and red dash lines represent the ratio of 
currents recorded in the presence of substrate for the wild type rEAAT4 transporter. *, p<0.05.  
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3.2.5 The mutant carriers R388A and R388D have dramatically increased anion leak 
currents  
The smaller ratio of I+Glutamate to I-Glutamate at +60 mV in the mutant carrier R388A compared to 
the wild type EAAT1 transporter and the mutant R388K indicates either changed anion leak 
conductance or substrate-activated anion current when neutralizing the arginine charge (Figure 
24).  Because the mutant carrier R388D displays no glutamate-activated anion current and the 
transporter exists predominantly in the anion leak state (Figure 25 and 26), we hypothesized that 
the anion leak conductance might also be increased in the mutant carrier R388A, which would 
result in a decreased ratio of I+Glutamate to I-Glutamate at +60 mV. Consistent with this idea, the         
I-Glutamate of R388A is generally larger than that of the wild type EAAT1 or the mutant R388K 
(Figure 24). Alternatively, R388A could express more on the cell surface, leading to large         
I-Glutamate, but have decreased I+Glutamate, which will also result in a decreased ratio of I+Glutamate to    
I-Glutamate at +60 mV. Thus we assessed the relative surface expression levels of transporter 
proteins, and normalized the anion leak current to transporter surface density. We recorded I-
Glutamate using NO3- as the permeating anion and also determined the cell surface expression of 
transporter proteins from the same batch of injected oocytes. When normalizing the NO3- current 
at +60 mV to their respective surface expression levels, we found that the Na+-activated anion 
leak current of the mutant R388A is significantly increased relative to the wild type EAAT1 
transporter, and the anion leak current of the mutant carrier R388D is even larger (Figure 28A).  
R388 is located close to TM2 residue D112 in the outward-facing GltPh structure (Figure 
28B). Previous studies have shown that neutralizing D112 with alanine also leads to a large 
increase in the anion leak current, raising the possibility that R388 may interact with D112 to 
control gating of the anion channel in human EAAT1. To test this hypothesis, we attempted to 
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restore substrate-elicited anion currents in the mutant R388D by introducing a positive charge at 
position D112. Unfortunately, this attempt was not successful. Even though the double mutant 
carrier R388D_D112R expresses well on the cell surface as indicated by a larger I-Glutamate 
compared to water-injected oocytes, it does not display substrate-elicited anion currents (Figure 
28C).  
3.2.6 The mutant carrier R388D spends more time in the inward-facing conformation in 
the absence of substrate 
During substrate transport, the transport domain moves toward the cell cytosol to allow 
cytoplasmic access of the substrate binding site. Such movement is intrinsic to the transporter 
protein and occurs in the absence of the substrate (50). Crisman et al. (94) have also shown that 
substrate accelerates the inward movement of the transport domain, while the non-transportable 
inhibitor TBOA blocks it (94). The characteristics of the inward movement of the transport 
domain are reminiscent of those of the anion channel function. Like the transport domain 
movement, the anion conductance occurs in the absence of substrate (activated by Na+), is 
blocked by TBOA and is increased by substrate. Thus, it is interesting to hypothesize that the 
transport domain movement may be linked to the anion channel function, and that the negative 
charge we introduced at position R388 might alter the conformation or limit the movement of the 
transport domain. 
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Figure 28. The mutant carriers R388A and R388D have dramatically increased anion leak currents 
Wild type EAAT1 and the mutant carriers (R388A, R388D, and R388D_D112R) were expressed in Xenopus 
oocytes. (A) Currents in the absence of substrate were recorded in NO3- containing solutions. Surface expression 
levels were determined using cell surface biotinylation assays from the same batch of injected oocytes. Relative 
anion leak currents were obtained after normalizing to respective surface expression levels and data were normalized 
to wild type EAAT1 transporters. (B) Residues equivalent to R388 and D112 of human EAAT1 were highlighted in 
blue spheres based on the crystal structure of GltPh (PDB ID: 1XFH). (C) Currents in the absence (black circle) and 
presence of 1 mM L-glutamate (red triangle) were recorded using NO3- as external anions. Endogenous currents 
were also included by recording water-injected oocytes (open diamond). 
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We first assessed the affinity of substrate for the mutant carrier R388D, reasoning that 
any change in the conformation of the transport domain could affect the extracellular 
accessibility of the substrate binding site. Because R388D accumulates substrate very poorly, but 
has a large Na+-activated anion leak current (Figure 23 and 26), we determined the affinity of 
TBOA by measuring TBOA-blocked anion leak current. Our results showed that the Km for 
TBOA is increased in the mutant carrier R388D compared to the wild type transporter (2.22 ± 
1.08 µM for the wild type EAAT1 and 12.83 ± 1.08 µM for the mutant R388D), consistent with 
the idea that the substrate binding site in the mutant carrier is less accessible (Figure 29A).  
To probe the conformation of the transport domain in the mutant carrier R388D, we took 
advantage of several previously characterized cysteine substitutions that demonstrate 
conformational sensitivity to thiol modification, particularly with respect to the transport domain 
movement (Figure 18A). We have observed that L376C displays the greatest sensitivity to 
conformational changes in the transport domain among the residues we have examined so far. 
We thus introduced L376C into the R388D background, and determined the accessibility of 
L376C to the membrane permeable thiol-modifying agent, NEM, under Na+ (the transport 
spends most of the time in the outward-facing orientation) or K+ conditions (in the inward-facing 
orientation). As expected, glutamate elicits a large NO3+ current in the single mutant carrier 
L376C, but no additional glutamate-elicited currents are seen in the double mutant carrier 
R388D_L376C (Figure 29B). R388D_L376C is expressed on the oocyte cell surface because 
oocytes expressing the mutant carrier have a larger I-Glutamate compared to water-injected oocytes 
(Figure 29B). We treated oocytes expressing transporter carriers with 0.25 mM NEM, a 
condition that has very different modification rates of L376C in Na+ and K+ containing solutions. 
5 min incubation with 0.25 mM NEM in Na+ solution does not inhibit the uptake activity of 
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L376C. In contrast, L376C shows 63.21 ± 9.82% of transport activity after NEM treatment in K+ 
solution (Figure 29C), due to the increased frequency of the inward movement of the transport 
domain by high extracellular K+ and the intracellular exposure of L376C  enabling NEM 
modification. It should be noted that when expressed in COS7 cells, treatment with 0.25 mM 
NEM in a solution with high extracellular K+ almost completely inhibits the uptake activity of 
L376C. The large cell volume of Xenopus oocytes might affect the effective intracellular NEM 
concentration. Supporting this idea, we have observed that NEM non-specifically inhibits 
transport activity of the CSLS control carrier by approximately 20% in COS7 cells, but not of the 
R388D single mutant carrier expressed in Xenopus oocytes. After 5 min treatment with 0.25 mM 
NEM in the Na+ condition, oocytes expressing the mutant carrier R388D_L376C displays 42.51 
± 4.38% of transport activity compared to the untreated control, suggesting that residue L376C is 
already exposed intracellularly in the Na+ condition. Modification with NEM in the K+ condition 
does not further inhibit the transport activity of the mutant carrier R388D_L376C (Figure 29C). 
Thus, the mutation of R388 to aspartate appears to cause the transport domain spend more time 
in the inward-facing orientation in the absence of substrate, which is in line with the decreased 
accessibility of the substrate binding site from the extracellular environment. 
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Figure 29. The mutant carrier R388D spends more time in the inward-facing conformation in the absence of 
substrate compared to the wile type transporter 
Wild type EAAT1 and mutant carriers (R388D, L376C, and R388D_L376C) were expressed in Xenopus oocytes. 
(A) Currents in the presence of various concentrations of TBOA were recorded in NO3- containing solutions. 
Currents at +60 mV in the presence TBOA were normalized to that in the absence of TBOA. Note that the basal 
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current (I-Glutamate recorded in the presence of maximal concentration of TBOA) was subtracted for the normalization. 
(B) Currents in the absence (black circle) and presence of 1 mM L-glutamate (red triangle) were recorded using 
NO3- as external anions. Endogenous currents were also included by recording water-injected oocytes (open 
diamond). (C) Oocytes expressing mutant carriers were treated with 0.25 mM NEM for 5 min under Na+ or K+ 
conditions as indicated. Uptake assays were performed for 15 min at room temperature using 5 μM L-[3H] glutamate 
as substrate. Data are normalized to the Na+ column. 
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3.3 DISCUSSION 
Glutamate transporters possess dual functions to clear extracellular glutamate and to conduct 
anions. Mutagenesis studies obtained so far suggest that these two functions seem to be mediated 
by independent processes. Modification of cysteine substituted residues in HP2 abolishes 
substrate transport, but the substrate-activate anion channel activity remains (96-98). On the 
other hand, mutating several charged or polar residues in TM2, 5 and 7 affects the anion channel 
function with modest changes in the substrate transport (95, 99). However, because both 
substrate transport and the substrate-activated anion current require the presence of Na+ and 
glutamate, these two functions must utilize similar structural components at various steps in the 
two processes. The present study shows that a conserved residue R388 in TM7 of human EAAT1 
serves a critical role in both substrate transport and anion conduction. Neutralizing R388 with 
amino acid alanine significantly impairs uptake activity compared to wild type transporters, and 
increases the Na+-activated anion leak current. The mutant carriers R388D and R388E 
accumulate substrate through an electroneutral process and also abolish the substrate-activated 
anion current (Figure 22-25).  
R388 is located one helix turn away from two other conserved basic residues, K384 and 
R385 in TM7. Mutant carriers with K384 or R385 replaced by either amino acid alanine or 
aspartate generally have similar rates of substrate transport and the voltage dependence of 
transport currents compared to wild type transporters. In addition, they display both changed 
Na+-activated anion leak current and the substrate-activated anion current (99). In our study, the 
mutant carrier R388A accumulates only ~20% of radioactive L-glutamte relative to the wild type 
transporter. The transport current at -100 mV is also decreased to a similar degree, although the 
voltage dependence of the transport current is unchanged (Figure 22). We also examined the cell 
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surface expression of R388A and concluded that the impaired substrate transport is not due to the 
decreased surface protein level. Thus, residue R388 is important for substrate transport. This is 
not so surprising in that TM7, as part of the transport domain, contributes to form the binding 
pocket for substrate and coupled ions, and moves inward to enable the alternating access of the 
binding pocket to the EC or IC environment.  
The involvement of the residue R388 in substrate transport is also supported by the 
phenotype of the mutant carriers R388D and R388E. Although these two mutants still 
accumulate radioactive substrate, no substrate-coupled transport current is observed. For a 
complete transport cycle, the inward movement of each glutamate molecule is coupled to the 
influx of 3 Na+, 1 H+ and the efflux of 1 K+, which generates two positive charges (Figure 1). If 
the mutant carriers R388D and R388E accumulate radioactive substrate by making a full cycle, 
the absence of coupled currents would suggest that the stoichiometry of coupled ions and 
glutamate is altered in these two mutants. Alternatively, radioactive substrate can be accumulated 
through a process called exchange, in which the K+-induced reorientation step is impaired and 
the transport returns to the outward-facing state by moving intracellular substrate and coupled 
ions outside the cell (Figure 1A). The K+-induced reorientation step is very vulnerable and 
several mutations have been reported to impair this step (64, 66, 79). The general properties of 
forward and reverse glutamate transport are symmetric (128). Experimentally, high extracellular 
K+ applied to cells expressing the wild type transporter leads to reverse transport, with release of 
intracellular substrate and co-transported ions and gating of the anion conductance. However, 
mutants with the impaired K+-induced reorientation step lose their ability to elicit anion currents 
when high concentrations of K+ are applied outside. Our preliminary results show that raising 
extracellular concentrations of K+ does not elicit any NO3- current in the mutant carriers R388D 
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and R388E (data not shown), similar to what has been observed for the mutants that impair the 
K+-induced reorientation step. However, we found later that glutamate no longer elicit additional 
anion current during forward transport for these two mutants (Figure 25) and thus the inability 
of high extracellular K+ to elicit anion currents could be due to the fact that no substrate-
activated anion currents are associated with reverse transport in the mutant carriers R388D and 
R388E. Nevertheless, our results show that reversing the positive charge of R388 with either 
aspartate or glutamate results in accumulation of radio-labeled substrate through an 
electroneutral process, supporting the role of R388 in substrate transport. 
Traditionally, the substrate-activated anion current is obtained by subtracting current in 
the absence of substrate from that in the presence of substrate. Because the Na+-activated anion 
leak current is blocked by non-transportable inhibitors such as TBOA, this current is obtained by 
subtracting current in the presence of inhibitors from that in the absence of inhibitors. In 
addition, more permeable anions such as NO3- and SCN- are used to study anion channel 
function. When comparing the subtracted currents between wild type and mutant transporters, 
variations arise within oocytes of different batches and sometimes even of the same batch 
because of inconsistent expression.  In our study, we plot currents recorded in the absence of 
substrate (I-Glutamate) and in the presence of substrate (I+Glutamate) without subtraction. Currents 
recorded at +60 mV, the most positive potential in our recording, are used to compare the anion 
channel activity because at this voltage the majority of current is due to the anion flow. The ratio 
of I+Glutamate to I-Glutamate at +60 mV is not significantly influenced by the expression of transporter 
proteins, even though both I-Glutamate and I+Glutamate contain endogenous oocyte currents (Figure 
24). This is because endogenous oocyte currents are generally small compared to I-Glutamate or 
I+Glutamate. Furthermore, comparison of I-Glutamate with endogenous oocyte currents from the same 
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batch provides a means to quickly determine if transporter proteins are expressed on the cell 
surface. The ratio of  I-Glutamate to I+Glutamate at +60 mV for the mutant carrier R388A is 
significantly smaller than that for the wild type EAAT1 transporter and the mutant carrier 
R388K, suggesting that either the Na+-activated anion leak current or the substrate-activated 
anion current is altered in the mutant carrier R388A. Further determination of the Na+-activated 
leak current after normalizing to the cell surface expression suggests that the mutant R388A has 
a larger Na+-activated leak current compared to the wild type EAAT1 transporter (Figure 28A).   
Surprisingly, even though the mutant carriers R388D and R388E still accumulate 
radioactive substrate, no glutamate-elicited anion current is observed (Figure 25). This 
phenotype is also seen in the equivalent charge reversing mutant of rat EAAT4, rEAAT4 R410E 
(Figure 27). Detailed analysis of the mutant carriers R388D and rEAAT4 R410E show that these 
mutants predominantly exist in the anion leak state. Consistent with this observation, the mutant 
R388D has a larger Na+-activated leak current after normalizing to the cell surface expression 
compared to the wild type EAAT1 transporter (Figure 28A). Thus, mutating the arginine to 
negatively charged amino acids prevents glutamate from gating the anion channel and therefore 
glutamate is no longer able to increase anion permeation. Taken together, these results suggest 
that R388 in TM7 plays a critical role in the anion channel function.  
We initially speculated that residue R388 might interact with residue D112 in TM2 
through charge attractions based on following observations. First, the mutant carrier D112A 
display increased Na+-activated anion leak current, but decreased substrate-activated anion 
current (95). This phenotype is very similar to that for the mutant R388A, but is not observed in 
the mutant R388K when the positive charge is preserved. Second, although the residues 
corresponding to R388 and D112 are conserved within mammalian EAATs, in GltPh the 
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corresponding residues are both serine, suggesting a potential co-evolution of residues. Third, 
based on the outward-facing crystal structure of GltPh, the Cα atom distance between residues 
equivalent to D112 and R388 is ~13 Å. Forth, the equivalent residue of D112 in GltPh is located 
in the TM2-TM3 loop, which undergoes significant conformational changes to accommodate the 
inward movement of the transport domain, where residue R388 resides (50). We attempted to 
restore the substrate-activated anion current by reversing the charges of R388 and D112 to 
maintain their potential interactions. However, glutamate does not elicit additional anion currents 
in the double mutant carrier R388D_D112R. The side chains of D388 and R112 in the double 
mutant carrier might not face the right directions to allow interaction or in wild type transporters 
a network of charge interactions may exist instead of a simple R388_D112 interaction. 
Supporting the latter explanation, mutations of several charged residues near these two residues 
have resulted in altered anion channel function (95, 99). It is thus possible that the introduced 
negative charge might interfere with the network of charge interactions and change the 
conformation of the transporter protein.  
We considered the conformation of the transport domain because this domain contains 
binding sites for substrate and coupled Na+ that are required to activate the anion channel.  In 
addition, the transport domain moves inward into the cell cytosol, which may disrupt charge 
interactions of residues in TM7 with those in TM2 and TM5, gating the anion channel. By 
determining the accessibility of a conformation-sensitive cysteine residue L376C, our results 
show that the transport domain of the mutant carrier R388D spends more time in the inward-
facing orientation in the absence of substrate (Figure 29). Consistent with this observation, the 
affinity of TBOA to block Na+-activated anion leak currents is also decreased in the mutant 
carrier R388D, suggesting decreased accessibility of the substrate binding site from the 
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extracellular environment when the transport domain moves in. These results indicate that the 
movement of the transport domain, a critical step during substrate transport, is required for the 
anion channel gating. In the mutant carrier R388D, the transport domain shifts to the inward-
facing orientation and this renders the carrier in the anion leak state.  
Our results are also consistent with previous notions that the substrate transport process is 
tightly linked to the anion channel function. Early evidence showed that fast application of 
glutamate elicits pre-steady state currents for both the transport current and the anion current, 
which then decay to steady state currents. These currents can be mathematically modeled by 
going through connected states occupied at similar early steps in the transport cycle (124). 
Grewer and colleagues rigorously studied the kinetics, Na+ and voltage dependence of these pre-
steady state currents (34, 126). They found that the pre-steady state of the anion current rises 
more slowly and the rising time constant is in the same range as the fast decay phase for the 
transport current (both called τfast). The decay phase of the anion current is best fit with one 
exponential component and is similar to the slow decay phase for transport current (τslow), 
suggesting that at least two phases (τfast and τslow) of the pre-steady state transport currents and 
anion currents share similar kinetic steps of the transport cycle. Additional experiments 
examining the Na+ and voltage dependence of these phases support this conclusion (88, 126). 
Interestingly, the activation enthalpies of these two processes are very large, indicating they are 
rate-limited by substantial conformational changes of the transporter (88). In light of our results, 
we attribute one of the conformational changes to be the inward movement of the transport 
domain.  
 Together, our results show that a positively charged residue in TM7 is invovled in both 
substrate transport and the anion channel function. By studying the charge-reversing mutants, 
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this study also suggests for the first time how the inward movement of the transport domain, a 
critical step of substrate transport, might be linked to the anion channel function. Our study 
opens new avenues toward a complete understanding of the complex dual mechanism carried by 
glutamate transporters.     
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4.0  SUBUNIT INTERACTIONS OF GLUTAMATE TRANSPORTERS  
4.1 INTRODUCTION 
Glutamate transporters are multimeric proteins composed of three identical subunits that line a 
small central hole (48, 55, 57). In studies of ours (Figure 12) and others (57), protein samples 
collected from oocytes expressing human EAAT1 or EAAT2 migrate predominantly as a single 
trimer species in blue native polyacrylamide gels. Virtually no dimer or monomer species is 
seen, suggesting that the trimerization of monomers occurs efficiently during or shortly after 
synthesis of the individual subunits.  
One fundamental question associated with multimeric structures is whether the individual 
subunits function independently of each other or whether there is cross-talk between them. It has 
been shown that the Hill coefficient for glutamate dependence of substrate transport is close to 
one, suggesting that only one glutamate molecule needs to bind to the transporter to be 
transported (34, 123). Grewer et al. (56) further explored this question by coexpressing wild type 
EAAT3 transporters and mutant transporters that have different substrate specificity and kinetic 
properties. Although the wild type and mutant transporters coassemble into trimers, they behave 
as two independent populations of transporters, leading to the conclusion that the individual 
subunits in the glutamate transporter trimer function independently of each other in both 
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substrate transport and anion conduction (56). Several other studies generally agree with this 
notion (115, 122).  
In contrast, Torres-Salazar et al. observed sigmoidal glutamate concentration dependence 
for the anion conduction with Hill coefficients ≥3 in EAAT4 (123).  Because it is sometimes 
difficult to draw conclusions about cooperativity based only on Hill coefficients, the authors also 
showed that in contrast to the early findings, cells coexpressing wild type EAAT4 transporters 
and mutant transporters do not show characteristics of two independent populations of 
transporters in the anion channel function (123). Based on these results, the authors concluded 
that multiple glutamate binding sites must be occupied to activate the anion channel, similar to 
ideas proposed to explain the behavior of ligand-gated channels such as acetylcholine receptors 
(129). Apart from the different transporter subtypes used experimentally in this study and the 
Grewer’s (56), the basis for the differences in the results remains unresolved. One explanation 
might be the untested assumptions of random translation and interaction of wild-type and mutant 
subunits expressed at the plasma membrane. The coexpression strategy theoretically results in 
four populations of glutamate transporters, comprised of either three wild type subunits, two 
mutant and one wild type subunits, one mutant and two wild type subunits, or three mutant 
subunits. The steady-state data essentially come from a mixed population of transporter trimers 
and in practice it is very difficult to determine the percentage contribution of each population to 
the total transporter function. Thus, fitting data to a model based equation may be problematic, 
since the information on the contribution of each population is not available. To overcome this 
shortcoming, we constructed a tandem-linked trimeric glutamate transporter. This concatenated 
glutamate transporter has 3 identical subunits connected by flexible linkers, each harboring 
unique restriction sites that enables us to “cut and paste” mutant subunits in any combinations 
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desired. The advantage of this concatenated gene is that it generates a homogeneous population 
of transporters with fixed stoichiometry of mutant and wild type subunits. Using this concatemer 
strategy, our preliminary data suggest that glutamate transporters are functional as trimers and 
the individual subunits transport substrate independently. 
4.2 RESULTS 
4.2.1 Characterization of a concatenated glutamate transporter trimer 
We made a concatenated glutamate transporter trimer by linking three cysteine-less EAAT1 
subunits (CSLS) at the DNA level. The linkers used are “GYPYDVPDYAGSAAISAAAAAAA 
AAAAA” and “AAAAAAAAAAAAGSAAISAAAAAAAAAAAA”. We named this construct 
as “1WT2WT3WT”, in which the number corresponds to the position of the subunit in the 
concatemer and the letter “WT” represents cysteine-less EAAT1. When expressed in COS7 cells, 
the concatenated carrier displays ~30 percent of uptake activity compared to the wild-type 
transporter (Figure 30A) and it also has comparable substrate affinity of transport activity (53.31 
± 15.18 µM for the wild type EAAT1 transporter vs. 28.09 ± 8.56 µM for the 1WT2WT3WT 
concatemer).  It should be noted that the concatenated carriers takes 3 days after cell transfection 
to achieve this substrate transport level. Similar to the wild type EAAT1 transporter, substrate 
transport of the concatenated carrier depends on sodium ions and can be inhibited by the 
presence of TBOA, a common non-transporting inhibitor of glutamate transporters (Figure 
30B), suggesting that the concatenated glutamate transporter has functional characteristics 
similar to that of the wild type EAAT1 transporter. To exclude the possibility that the 
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concatenated carriers form higher order oligomers between concatemers, we performed blue 
native gel analysis to determine the quaternary structure of proteins. Both the wild type EAAT1 
transporter and the concatenated carrier migrate predominantly as a single trimer species and no 
other apparent species at higher molecular weight is observed (Figure 30C). The concatenated 
carrier runs a little bit slower, which may be due to the two linkers inserted into the protein. 
When the concatenated carrier is denatured and separated by SDS-PAGE, the majority of species 
migrate at a molecular weight of >190 kDa, corresponding to the size of a trimeric glutamate 
transporter. In contrast, the wild type EAAT1 transporter displays a monomer species of ~70 
kDa and an additional species at ~140 kDa, which arises from the aggregation of glutamate 
transporters (Figure 30D). Thus, the concatenated glutamate transporter carriers self-assemble 
into trimer and are highly functional.  
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Figure 30. Characterization of a concatenated glutamate transporter trimer 
The wild type EAAT1 transporter and the concatenated carrier 1WT2WT3WT were expressed in COS7 cells. (A) 3 
days post transfection, uptake assays were performed for 10 min at room temperature using concentrations of L-[3H] 
glutamate as indicated. (B) Uptake assays were carried out using 5 µM L-[3H] glutamate as substrate in the absence 
and presence of 384 μM TBOA. For Na+ dependence, sodium ions were replaced by equal molar of choline. (C) 
Proteins samples were separated by blue native PAGE. (D) Proteins samples were separated by SDS PAGE. Lane 1: 
the wild type EAAT1 transporter, Lane 2: the concatenated carrier 1WT2WT3WT. Glutamate transporter proteins 
were identified using an anti-human EAAT1 polyclonal antibody directed against the C-terminus. 
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4.2.2 The mutant carrier R479C in human EAAT1 changes its substrate specificity 
It has been shown previously that the neutralization of a conserved arginine residue R447 results 
in the conversion to neutral amino acid substrate specificity in a neuronal glutamate transporter 
EAAC1. Whereas wild type EAAC1 is capable of accommodating both L-glutamate and L-
cysteine as substrates, several EAAC1 R447 mutants do not bind acidic amino acids, but are able 
to transport L-cysteine and other neutral amino acids, such as L-serine, which is not a substrate 
for the wild type transporter (64). When coexpressed with the wild type EAAC1 transporter, a 
population of the assembled trimers are composed of individual subunits that transport either L-
glutamate or L-serine. Using this strategy, Grewer et al. showed that the amplitudes of anion 
currents elicited at 0 mV by the mixture of two substrates is identical to the sum of the anion 
current amplitudes activated by the application of either L-glutamate of L-serine alone. Data 
obtained by coexpressing human EAAT4 and the equivalent arginine mutant show different 
results, thus reaching distinct conclusions on the subunit interactions of the anion channel 
function. We intend to revisit this question by generating concatenated heterotrimers that allow 
the expression of a single population of the heterotrimers containing subunits that transport either 
L-glutamate or L-serine. With these constructs, we can address the following questions: a) Is a 
single subunit capable of transporting substrate and conducting anions, and b) Is there cross-talk 
between subunits?   
We first mutated the equivalent arginine residue in human EAAT1 (R479) to cysteine 
and tested the substrate specificity of the mutant carrier in oocytes. As shown in Figure 31, 
application of 1 mM L-glutamate to oocytes expressing the WT EAAT1 transporter elicits an 
outward NO3- current +60 mV, whereas 1 mM L-ser or L-alanine does not elicit any detectable 
currents. With the mutant R479C, 1 mM L-serine or L-alanine elicits an outward NO3- current, 
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but 1 mM L-glutamate does not (Figure 31). These results demonstrate that the function of the 
arginine residue is conserved in different subtypes of mammalian transporters. The mutant 
carrier R479C changes its substrate specificity from preferring acidic amino acids to neutral 
amino acids.   
 
 
 
 
 
 
 
 
Figure 31. The mutant carrier R479C in human EAAT1 changes its substrate specificity 
The wild type EAAT1 transporter and the mutant carrier R479C were expressed in Xenopus oocytes. Currents 
elicited by 1 mM L-glutamate, 1 mM L-serine or 1 mM L-alanine were recorded using NO3- as external anions. The 
oocytes were clamped at a membrane potential of +60 mV. Open bars on the top of current traces represent the 
application of the substrates. 
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4.2.3 A single subunit of glutamate transporter trimer is capable of transporting 
substrate  
We next replaced one or two subunits in the concatenated 1WT2WT3WT with the R479C 
mutant subunit(s) and asked whether a single subunit is capable of transporting substrate. The 
concatenated carrier 1WT2WT3R479C, which contains a single R479C subunit in the third 
position, is able to accumulate radioactive L-serine (Figure 32A). Similarly, the concatenated 
carrier 1WT2R479C3R479C, which contains only one wild type EAAT1 subunit, transports L-
glutamate (Figure 32B). These results indicate that a single transporter subunit within a trimer is 
capable of transporting substrate.  
 
 
 
 
 
 
 
 
 
 
 
Figure 32. A single subunit of the glutamate transporter trimer is capable of transporting substrate 
The concatenated carriers (1WT2WT3WT, 1WT2WT3R479C, and 1WT2R479C3R479C), the EAAT1 mutant 
carrier R479C and the wild type human ASCT1 were expressed in COS7 cells. 3 days post transfection, uptake 
assays were performed for 10 min at room temperature using 100 nM L-[3H] serine (A) or 5 μM L-[3H] glutamate 
(B) as substrates. 
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4.2.4 Each subunit of the glutamate transporter trimer uptakes substrate independently 
from each other  
To examine the potential subunit interactions on transporting substrates, we tested whether the 
substrate transport capability of one subunit is influenced by the function of a neighboring 
subunit in the trimer. We compared the accumulation of radioactive L-glutamate by the 
concatenated carriers 1WT2WT3R479C and 1WT2R479C3R479C in the absence or presence of 
500 μM unlabeled L-serine. No significant difference in L-glutamate accumulation is observed 
for both concatenated carriers 1WT2WT3R479C and 1WT2R479C3R479C using either 5 μM 
(Figure 33A) or 500 μM L-[3H] glutamate (Figure 33B) as substrate, suggesting that each 
subunit transports substrate independently.  
4.3 DISCUSSION 
In this study, we made a concatenated gene by linking three glutamate transporter subunits at the 
DNA level. This concatenated carrier is highly functional and assembles as a trimer in 
mammalian cells. These results confirm that glutamate transporters can function through a 
trimeric stoichiometry. We further studied subunit interactions by introducing into the 
concatenated carrier mutant subunit(s) that only transport neutral amino acids. We found that a 
single glutamate transporter subunit is capable of transporting substrate. In addition, each subunit 
functions independently in substrate transport. To explore whether a single subunit of glutamate 
transporters is able to conduct anion currents and whether there are interactions between subunits 
during this process, we expressed the concatenated carriers in Xenopus oocytes. Unfortunately, 
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despite the success at expressing the concatenated trimer constructs in mammalian cells, 
expression of these carriers in oocytes has proved difficult thus far. Further studies using patch 
clamping in mammalian cells or improved expression in oocytes will help delineate the subunit 
interactions of glutamate transporters in the anion channel function.  
 
 
 
 
 
 
 
 
 
 
Figure 33. Each subunit of the glutamate transporter trimer uptakes substrate independently from each 
other 
The concatenated carriers 1WT2WT3WT, 1WT2WT3R479C, and 1WT2R479C3R479C were expressed in COS7 
cells. 3 days post transfection, uptake assays were performed for 10min at room temperature using 5μM L-[3H] 
glutamate (A) or 500μM L-[3H] glutamate (B) as substrate in the absence or presence of 500 µM unlabeled L-serine.  
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5.0  CONCLUSIONS, GENERAL DISCUSSIONS AND FUTURE DIRECTIONS  
Neuronal and glial glutamate transporters function to clear synaptically released glutamate from 
the extracellular space. This process not only ensures the spatial and temporal fidelity of 
excitatory signaling, but also prevents the neuronal death triggered by excess glutamate (130). In 
addition, glutamate transporters possess a substrate-gated anion channel function, which may 
play an important role in shaping the synaptic transmission. The overarching questions that have 
driven this thesis project are how these two distinct functions can take place within a glutamate 
transporter trimer and what are the domains and domain movements required for glutamate 
transport and/or the anion channel function 
As described in Chapter 2, we have used cysteine crosslinking in combination with 
computational simulations to obtain evidence for large-scale collective movements of the 
glutamate transporter trimer that are functionally important. Two types of these movements are 
suggested by the ANM analysis: asymmetric contraction/stretching and symmetric 
opening/closing. In both modes, the extracellular domains of adjacent subunits approach each 
other, whereas residues at the bottom of the transporter, within the membrane, remain rigid. 
Restricting these motions by the formation of disulfide bonds between two subunits of a trimer 
completely abolishes substrate transport. In addition, when two subunits approach each other and 
are crosslinked, the transport domain of the third uncrosslinked subunit assumes an inward-
facing orientation, suggesting that the large collective movements of the transporter trimer are 
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functionally linked to the piston-like movement of the transport domain. The ANM analysis also 
confirms that individual subunits potentially undergo separate transitions between outward-
facing and inward-facing forms, rather than an all-or-none transition of the three subunits.  
Finally, glutamate still elicits anion currents after crosslinking, presumably through two 
crosslinked subunits that have limited capability to move. Thus, substrate-activated anion 
conduction likely occurs at an early step of the transport cycle without significant conformational 
changes. 
We went on to explore the anion permeation pathway and the conformational changes 
associated with the anion channel function in Chapter 3. A conserved arginine residue in TM7 
was identified to be important for both substrate transport and the anion channel function. This 
positively charged residue, R388 in human EAAT1, displays impaired substrate transport 
activity when mutated to the neutral amino acid alanine. The mutant carrier R388A also has 
increased Na+-activated anion leak currents, but decreased substrate-activated anion currents. 
When R388 is replaced with a negatively charged amino acid, such as glutamate or aspartate, the 
mutant carriers R388D and R388E accumulate radioactive substrate through an electroneutral 
process, and abolish the ability of substrate to elicit additional anion currents. The transport 
domain in the mutant carrier R388D spends a longer time in the inward-facing orientation, 
pointing to the possibility that the piston-like movement of the transport domain, a critical step 
during substrate transport, might also be involved in the anion channel function.  
Finally, we constructed a concatenated glutamate transporter trimer in Chapter 4, which 
has functional characteristics similar to the wild type transporter. Using this concatenated 
construct, we concluded that a single glutamate transporter subunit is capable of transporting 
substrates and its transport activity is not influenced by the activity of adjacent subunits. 
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In summary, data presented in this dissertation expand our understanding of domains and 
conformational changes associated with these domains critical for glutamate transporter dual 
functions.  As is always true in scientific research, our results stimulate more questions than they 
answer. In the following sections, I will discuss the implication of our proposed mechanisms and 
areas of future research.  
5.1 LARGE COLLECTIVE MOVEMENTS PROVIDE A DIFFERENT VIEW TO 
UNDERSTAND THE ALTERNATING ACCESS MECHANISM OF GLUTAMATE 
TRANSPORTERS 
The successful crystallization of the archaeal glutamate transporter homolog GltPh marks a new 
chapter in studying the structure and function of this protein family, which started decades ago 
with the discovery of transport systems that use the gradients of ions across the cell membrane to 
concentrate glutamate. Each structure crystallized under a specific condition (substrate-bound, 
TBOA-bound and crosslinked) provides tantalizing clues of how these proteins work through the 
alternate accessing mechanism. This mechanism contends that the transporter isomerizes 
between an outward-facing and an inward-facing conformation, in which the substrate binding 
site is alternatively accessible from the external and internal solutions. Two conceptual models 
have been proposed to fulfill this mechanism by different proteins. The canonical model, called 
‘gated pore’, involves the presence of two gates—one external and one internal. The two gates 
flank the substrate binding site and open sequentially to allow alternate accessing (86). Examples 
of carriers using this model include the H+/Cl- exchanger of the CLC family (131). The ‘rocker-
switch’ model, on the other hand, focuses on the rocking movements of protein domains, usually 
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through a global conformational change that pivots at the substrate binding site (132). Members 
of the major facilitator superfamily (MFS), such as lactose permease, belong to this category 
(133). Glutamate transporters seem to integrate both models. In the substrate-bound 
conformation of GltPh, the two hairpin loops HP1 and HP2 cradle the substrate binding site. 
Molecular dynamics simulations show that the HP2 loop opens up within tens of nanoseconds 
and remains open during 40 ns duration of the simulation (Figure 15, Chapter 2 and (89)). 
Consistent with these results, HP2 is displaced from the substrate binding site in the TBOA-
bound conformation of GltPh, due to the hindrance of the large benzyl group of TBOA (49), 
supporting the idea that HP2 serves as an external gate. Based on the ‘gated pore’ model, HP1 
may serve as the internal gate. Mutagenesis studies exploring the accessibility of residues in this 
region also support this notion (92). The conformation of GltPh with HP1 open is not yet 
available. Steered-MD simulations suggested the existence of two large energy barriers along the 
putative intracellular substrate pathway aligned by HP1, TM7 and TM8 (134). Such energy 
barriers will be relieved by the opening of the HP1 gate. On the other hand, initial evidence 
supporting the ‘rocker-switch’ model was obtained by crosslinking two introduced cysteines in 
TM2 and HP2. This structure, known as the inward-facing conformation, reveals the inward 
movement of the transport domain into the cell cytosol that is necessary to expose the substrate 
binding site intracellularly. The surface representations of the substrate bound and crosslinked 
structures clearly show the alternate access of the substrate binding site, in a similar manner as 
that of the ‘rocker-switch’ model in the MFS proteins (Figure 5D and 5E). However, the 
conformational changes adopted by the MFS proteins to achieve ‘rocker-switch’ model are quite 
different from the piston-like movement of the transport domain, but instead are similar to the 
large collective movements shown in our study. Thus, the large collective movements provide a 
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different view of how glutamate transporters achieve their functions through the alternating 
access mechanism.  
5.2 DETERMINATION OF THE FREQUENCY OF THE LARGE COLLECTIVE 
MOVEMENTS AS A MEANS TO ESTABLISH THEIR PHYSIOLOGICAL 
RELEVANCE  
Our cysteine crosslinking, accessibility and ANM analysis data are consistent with a 
conformational state of the glutamate transporter in which two subunits move towards each 
other, while the transport domain of the third subunit starts to move into the cell cytosol. 
Obtaining a crystal structure of a glutamate transporter trapped in this state will further confirm 
this prediction. Is this conformation frequently visited during substrate transport or are we just 
trapping some extreme condition that rarely occurs? These questions can be partially addressed 
by assessing the frequency of these large collective motions and how close the adjacent subunits 
might reach. Unfortunately, the ANM analysis is an analytical tool that only predicts the 
direction of global motions, and the exact amplitude and frequency of these motions cannot be 
inferred. In addition, current ANM technology does not include plasma membrane and it has 
been shown that the membrane composition influences the localization and function of glutamate 
transporters (135).  In our study, the second order rate constants calculated for the CuPh-
catalyzed functional inhibition are lower than those obtained in the previous work for Shaker K+ 
channels and the E. coli D-galactose receptor in which the two crosslinked cysteines are already 
very proximal in their respective structures (136-137). Instead, both the frequency of the large 
collective motions and the distance between reactive cysteines contribute to the reaction rate in 
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the present work and it is not possible to distinguish which has the greatest impact on the rate of 
bond formation. Based on the ratio of the eigenvalues computed by the ANM for the global 
modes to the eigenvalues computed for local (nanoseconds) events, we have estimated that the 
low frequency global modes take place at a time range of micro- to milliseconds. In line with the 
observation that intersubunit crosslinks readily occur between at least 8 cysteine pairs, we 
propose that the transporter does transit through the conformation(s) we capture at a relatively 
high and readily detectable frequency. Recently, the application of fluorescence at the single-
molecular level brings to life the dream of watching a single protein molecule functioning in real 
time, although not at the atomic level. This kind of technique can detect transient intermediates 
and the sequence of events that might be hidden in population-averaged measured. Using single-
molecule FRET, Diez et al. (138) successfully identified the step wise rotation of the γ subunit in 
F0F1-ATP synthase driven by the proton gradient. Zhao et al. (139) reported a process whereby 
substrate binding from the extracellular side of a Neurotransmitter/Na+ symporter (LeuT) 
facilitates intracellular gate opening and substrate release at the intracellular face of the protein. 
Similar application of single-molecule FRET in glutamate transporters will allow the assessment 
of the frequency of the large collective movements, and the discovery of other conformational 
changes required for transporter functions.  
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5.3 ADDITIONAL CROSSLINKING STUDIES TO ADDRESS THE RELATIONSHIP 
BETWEEN LARGE COLLECTIVE MOTIONS AND THE PISTON-LIKE MOVEMENT 
OF THE TRANSPORT DOMAIN 
Our results suggest that large collective movements of the glutamate transporter trimer can be 
functionally linked to the piston-like movement of the transport domain. However, it is currently 
unknown how they are associated. One intriguing hypothesis is that the large collective 
movements involving all three transporter subunits may provide the energy required for the 
transport domain movement, which is shown to occur in the absence of substrate and coupled 
ions (50). In our study, all of the intersubunit crosslinkable residues are located in the transport 
domain. Because the transport domain needs to move substantially during substrate transport, the 
inhibition of uptake could also be a consequence of inability of the transport domain to complete 
the required movement. Future studies could use similar strategy to crosslink residues in the 
scaffold domain (TM1-6) between two subunits. This kind of crosslinking would only restrict the 
large collective movements, but not the piston-like movement of the transport domain. Searching 
such crosslinkable residues based on the GltPh structures should proceed with cautions. Although 
the structural features of the transport domain are similar between the mammalian EAATs and 
GltPh, the structure of the scaffold domain in the mammalian EAATs is still an enigma. A recent 
study explored the proximity of residues between TM5 and TM8 in a rat transporter, GLT-1 
(140). The locations of the identified residue pairs, when mapped onto the GltPh structures, do 
not agree with the proximity suggested by the crosslinking data. Comparing to GltPh, the 
mammalian EAATs have an additional segment of over 50 amino acids in TM4, which contains 
the N-linked glycosylation sites. The structure of this segment and its relationship to the rest of 
the transporter are unknown. One study suggested that this segment extends from near the center 
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of the protein and that the majority of the residues are positioned on the outer perimeter of the 
protein (62). If this is true, this segment will also influence the ability of large collective 
movements that bring two adjacent subunits close together. In recent years, significant progress 
has been made to determine the atomic structure of membrane proteins by crystallography, 
benefited from a raft of technical advances including the application of high throughput 
platforms (141). With the advances of other biophysical methods, such as NMR spectroscopy  
and electron crystallography of 2D crystals in the presence of lipids (142-143), it is conceivable 
that the atomic structure of mammalian EAATs will be available in the near future, which will 
help the design of additional crosslinking studies to explore the importance of the large collective 
movements. 
5.4 LARGE COLLECTIVE MOVEMENTS AND THE GLUTAMATE BUFFERING 
THEORY 
In addition to facilitating substrate transport, the large collective movement of the transport 
trimer may influence glutamatergic signaling in other ways such as changing the buffering 
capacity of the glutamate transporter. It is no doubt that glutamate transporters play a crucial role 
in glutamatergic synaptic transmission. Several studies have shown that blocking glutamate 
transporters increases the amplitude or the decay time of excitatory postsynaptic currents (144-
145). However, the cycling time of glutamate transporters, estimated to range from 30 ms to 100 
ms (125-126, 146), is significantly slower than the time course of synaptically released 
glutamate, leading to the hypothesis that transporters remove free glutamate from the cleft very 
quickly primarily by binding, with transport to following on a longer timescale (147). Supporting 
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this buffering theory, chemical-kinetic simulations of currents evoked by the fast application of 
glutamate show that binding of glutamate to the transporters is very rapid, and occurs within 10-
100 µs at typical released glutamate concentrations (34, 125). Another parameter important for 
the buffering hypothesis is the rate of glutamate dissociation from the substrate binding site, 
which has been estimate to be about 500 µs to 2 ms (34, 125). Thus, glutamate also can come off 
the substrate binding site before being translocated. The three subunits of glutamate transporters 
form a bowl-shape structure. By measuring the binding and unbinding rates of a potent inhibitor, 
4-fluorenyl-L-aspartylamide, in the presence or absence of glutamate, Kavanaugh and colleagues 
suggested that the three subunits surrounding the large aqueous central cavity restrict diffusion of 
substrates out of the basin and facilitate transport efficiency (148). We propose that the large 
collective motions may also help prevent the escape of glutamate from the central basin and 
ensure the rapid clearance of glutamate from the extracellular space. One strategy to test this 
hypothesis is to crosslink adjacent subunits with bifunctional crosslinking reagents of different 
length, which theoretically will change the size and pore of the aqueous central cavity of 
glutamate transporters and influence the diffusion of substrates. Such studies will also establish 
how flexible the extracellular domains of glutamate transporters are required to carry out their 
functions, as has been shown for the lactose permease LacY (149).   
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5.5 EXPLORING THE ANION PERMEATION PATHWAY  
Our study has also identified for the first time two charge-reversing mutants of human EAAT1, 
R388D and R388E that abolish the substrate-activated anion current, but retain the ability to 
accumulate radioactive substrate. These mutants, together with others identified in the previous 
studies by Vandenberg and colleagues, suggest that TM2, TM5 and TM7 form the anion 
permeation pathway (95, 99). To obtain a complete picture of the anion permeation pathway, 
cysteine substituted mutants can be generated in this region and modification of the cysteines by 
thiol-modifying reagents should inhibit the permeation of anions if they line the pathway. This 
strategy has been successfully applied in Na+-K+ ATPase to identify the cation permeation 
pathway (150).  
5.6 LINKING THE INWARD MOVEMENT OF THE TRANSPORT DOMAIN TO 
THE ANION CHANNEL ACTIVITY  
An interesting hypothesis inferred from the characterization of the mutant carrier R388D is that 
the inward movement of the transport domain might be required for anion channel gating. 
Supporting this idea, TBOA inhibits an anion leak current when applied to the intracellular side, 
suggesting that the inward-facing transporter is also anion conducting (128). How deep does the 
transport domain have to move to gate the channel?  Our results suggest that a small movement 
might be sufficient because glutamate is able to activate the anion current when two subunits are 
crosslinked and have limited ability to undergo conformational changes. Further studies can 
utilize cysteine crosslinking studies to restrict the transport domain at positions along its 
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trajectory moving towards the cytoplasm and explore the consequence on the anion channel 
function. In addition, computational simulations might also help to elucidate the importance of 
the transport domain movement for gating the channel and to identify the anion permeating 
pathway.  
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6.0  MATERIALS AND METHODS 
6.1 MATERIALS 
All chemical were purchased from Sigma-Aldrich unless specified. MTS derivatives were from 
Toronto Research Chemicals Inc.  
6.2 MUTAGENESIS 
Mutant transporters were generated based on the appropriate cDNA template using a PCR-based 
site directed mutagenesis strategy (Stratagene). PCR products were then subcloned into empty 
vectors to avoid unexpected mutations in vectors and the transporter insertions were sequenced 
using dye terminator cycle sequencing (PerkinElmer).    
6.3 CELL CULTURE AND TRANSFECTION  
COS7 cells were maintained in DMEM medium containing 10% fetal bovine serum, 100 U/ml 
penicillin and 100 U/ml streptomycin in humidified air with 5% CO2 at 37 °C. Cells were 
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passaged, plated into 24-well plates or 6-well plates, and then transfected using Fugene 6 
(Roche) or TransIT®-LT1 (Mirus Bio LLC) according to the manufacturers’ guidelines.  
6.4 XENOPUS OOCYTE PREPARATION 
Female Xenopus laevis were ordered from the following commercial vendors (Nasco, Xenopus 
1, and Xenopus Express). Late-stage oocytes (stage V-VI) were removed from the ovaries of the 
adult female. Specifically, the frog was anesthetized in a chilled 0.1% tricaine solution for 15-25 
min. Once anesthetized, a one centimeter incision through the skin and abdominal muscle was 
made to one side of the ventral midline of abdomen. Autoclaved instruments were used for the 
extraction of ovarian tissue, and harvested oocytes were defolliculated for 60-90 min with 1.5 
mg/ml type 2 collagenase (280 U/mg; Worthington Biochemical Corp) in sterile OR2 solution 
containing: 82.5 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, and 5 mM Hepes, pH 7.4. After 
collagenase treatment, isolated oocytes were rinsed with OR2 and stored in ND96++ storage 
solution containing: 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM Hepes, 50 
µg/ml of gentamicin (Invitrogen) and 100 µg/ml amikacin (Sigma-Aldrich), pH 7.4 at 17°C. 
Oocytes were checked daily for death and rinsed with fresh ND96++ solution.  
6.5 RNA PREPARATION AND OOCYTE INJECTION 
cDNA sequence transcribing wild type and mutant transporters were subcloned into an oocyte 
transcription vector (pOTV) that utilizes Xenopus 6-globin 5’- and 3’- untranslated regions 
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derived from pSP64T to enhance expression (18). pOTV constructs containing transporter 
cDNAs were usually linearized with BamH I and capped RNAs were transcribed by using T7 
RNA polymerase provided in mMessage mMachine kits (Ambion). Approximately 10 ng RNAs 
(50 nl) were injected into defolliculated stage V to VI oocytes with a microprocessor-controlled 
nanoliter injector (World Precision Instruments, Inc.).  The oocytes were kept at 17 °C for 2-4 
days. 
6.6 CUPH-CATALYZED DISULFIDE BRIDGE FORMATION AND DTT 
APPLICATION 
COS7 cells expressing either wild type or mutant transporters were washed with phosphate-
buffered saline (171 mM NaCl, 10.1 mM Na2HPO4, 3.35 mM KCl, and 1.84 mM KH2PO4, pH 
7.4) and then incubated for 5 min at room temperature with various concentrations of CuPh or 20 
mM DL-dithiothreitol (DTT) in phosphate-buffered saline (PBS). CuPh was generated prior to 
experimental use by mixing CuSO4 and 1,10-phenanthroline in a 1:2 ratio. For DTT application 
after CuPh treatment, cells were washed with PBS and incubated with 20 mM DTT in PBS for 
an additional 5 min. Transporter-expressing oocytes were treated with CuPh or DTT in ND96 
solution similarly as described. 
 130 
6.7 UPTAKE ASSAYS AND TRANSPORT KINETIC MEASUREMENTS 
Uptake assays in COS7 cells were usually performed two days post transfection, except for 
experiments involving concatenated glutamate transporters (3 days post transfection). Briefly, 
cells were washed with phosphate-buffered saline solution plus 0.1 mM calcium chloride and 1 
mM magnesium chloride (PBSCM), and then incubated for 10 min at room temperature with 5 
μM L-[3H] glutamate (50 nM L-[3H] glutamate and 4.95 μM unlabeled L-glutamate).  After 
washing twice with cold PBSCM, cells were lysed in 0.1% SDS and counted in a Beckman 
scintillation counter. For Vmax and Km measurements, cells were washed once with PBSCM and 
then incubated with 7.8125, 15.625, 31.25, 62.5, 125, 250, 500, 1000 μM L-glutamate containing 
a fixed ratio of L-[3H] glutamate (1:10,000) for 10 min at room temperature. Vmax and Km values 
were determined using the Michaelis-Menten equation with the software package Prism 4.0 
(Graphpad software). Background L-glutamate uptake measured in cells transfected with the 
pCMV5 vector was subtracted for each condition. Uptake in Xenopus oocytes were performed 
similarly in ND96 solution using 5 μM L-[3H] glutamate as substrate for 15 min at room 
temperature.   
6.8 CALCULATION OF THE REACTION RATE CONSTANTS 
The reaction rate constants for CuPh-catalyzed crosslinking were determined as previously 
described (90, 151). We plot the fraction of uptake remaining (F = uptake after/uptake before) as 
a function of the concentration of CuPh and then fit to a non-linear regression equation for one 
phase exponential decay, F = Fmax × exp(-yct) - Fmin, where t is the incubation time in seconds (5 
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min), c is the concentration of CuPh reagent, and y is the second order reaction rate constant 
expressed as (M-1s-1). 
6.9 CELL SURFACE BIOTINYLATION 
Cell surface expression of transiently transfected transporters was assayed as previously 
described (152). Briefly, cells were washed with PBS and then incubated with 1.5 mg/ml NHS-
SS-biotin (Pierce) in biotinylation buffer (2 mM CaCl2, 150 mM NaCl, 10 mM triethanolamine, 
pH 8.0) for 30 min at 4 °C. For thiol-specific biotinylation assay, cells were treated with 1 mg/ml 
maleimide-PEO2-biotin (Thermo Scientific) or 1 mg/ml maleimide-biotin (Vector Labs) in PBS. 
Following the biotinlyation reaction, unreacted NHS-SS-biotin was quenched by the addition of 
100 mM glycine. Cells were then lysed on ice in 1 ml lysis buffer containing 1% Triton X-100, 
150 mM NaCl, 5 mM EDTA and 50 mM Tris, pH 7.5. The cell lysates were centrifuged at 
10,000 × g for 30 min.  The supernatants were collected and divided into two portions: a 50 µl 
aliquot was mixed with 50 µl 2 × SDS sample loading buffer to be used as total input, and the 
rest 950 µl was mixed with Ultralink Immobilized NeutrAvidin beads (Pierce) overnight at 4 °C. 
The beads were then washed and 1.3 × SDS loading buffer was added. Protein samples were 
incubated at 37 °C for 30 min before gel electrophoresis. 
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6.10 OOCYTE MEMBRANE PREPARATION 
Ooctye membranes were prepared as described by Kobilka with some modifications (105). 
Briefly, 6-12 oocytes were transferred into a microcentrifuge tube and pipetted to disrupt the 
membrane in 200 μl disruption buffer containing 7.5 mM NaH2PO4, 1 mM EDTA, 10 mM NEM 
and protease inhibitors (Roche), pH 7.4. The homogenate was then centrifuged for 5 min at 
3,000×g. The supernatant was transferred to a new tube and centrifuged at 10,000×g for 30 min. 
The yellow yolk was removed with a cotton swab and the collected membranes were dissolved 
with 40 μl disruption buffer containing 2% SDS.  
 
6.11 BLUE NATIVE POLYACRYLAMIDE GEL ANALYSIS 
BN/PAGE was carried out as described (153). Protein samples were collected from oocytes as 
described above and then homogenized in 500 μl of sucrose buffer (250mM sucrose, 20mM 
imidazole/HCl, pH 7.0). The samples were centrifuged for 10min at 10,000×g and the pellets 
were dissolved in 10% glycerol, 0.2% (wt/vol) Serva blue G, and 2% digitonin before loading 
onto 4-12% gradient native polyacrylamide gels (Invitrogen). For SDS PAGE, proteins were 
solubilized in 2% SDS and incubated at 56 ºC for 1 hr before electrophoresis. 
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6.12 WESTERN BLOTTING 
Proteins samples were generally separated on 4-12% or 8-6% Tris-glycine gradient 
polyacrylamide gels (Invitrogen), and transferred to a PVDF membrane (Millipore). Glutamate 
transporter proteins were probed with a polyclonal antibody against the C-terminus of EAAT1 
(1:1,000 dilution) (43), and other proteins such as β-actin were probed with optimized 
concentrations of antibodies. Proteins were visualized with a horseradish peroxidase (HRP)-
conjugated secondary antibody and chemiluminescent detection (PerkinElmer).  For protein 
quantitation, multiple exposures of Western blots were collected, and densitometry of 
appropriate images was performed using Image J software (NIH).  
6.13 ELECTROPHYSIOLOGY 
Two-electrode voltage clamp recordings were performed at room temperature using glass 
microelectrodes filled with 3 M KCl solution (resistance < 1 MΩ) and a Ag/AgCl wire and an 
active bath probe. An Axon Geneclamp 500B amplifier (Axon instruments) was used with 
Digidata 1322A interface. The pClamp suite of programs were used to control simulation 
parameters and for data acquisition and analysis. Oocyte recordings were routinely done in either 
frog Ringers (ND96) or anion substituted Ringers. For anion substitution experiment, NaCl was 
replaced with equal molar NaNO3 or NaSCN. We used a 3 M KCl/agar bridge to avoid offset 
voltages associated with anion buffer changes. To generate current-voltage (I-V) relationships, 
steady state currents were elicited by 150 ms voltage steps from a holding potential of -60 mV or 
0 mV over the range of -100 to +60 mV in 10 mV increments. 
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6.14 MOLECULAR DYNAMICS SIMULATIONS 
We simulated the dynamics of GltPh (PDB ID: 1XFH) embedded in a bilayer-solvent 
environment using the GROMACS program 3.2.1 with the Gromacs force field (154). The 
membrane consisted of 353 1-palmitoyl-2-oleoylphosphatidyl ethanolamine molecules, and the 
system was solvated with ~23,000 water molecules. Missing atoms on the side chains of some 
residues in the crystal structure of GltPh were constructed using Xplor (154). Constant number 
of particles (N), pressure (P), and temperature (T) conditions, with a pressure of 1 bar and a 
coupling constant of τp = 1.0 ps, were adopted. Water, protein, and lipid molecules were coupled 
separately to a temperature bath at 310 K using a coupling constant of τt = 0.1 ps. The van der 
Waals interactions were calculated using a cutoff distance of 10 Å, and long range electrostatic 
interactions were calculated using the particle mesh Ewald method. The single point charge 
model was adopted for water molecules as a plausible model for lipid simulations, along with the 
lipid parameters used for other membrane proteins (155). Simulations were preceded by energy 
minimization with steepest descent followed by equilibration periods of 200 ps during which the 
protein backbone atoms were restrained by harmonic potentials so as to allow for the packing of 
lipid molecules around the protein. The constraints were then removed for the productive runs. 
6.15 ANISOTROPIC NETWORK MODEL (ANM) ANALYSIS 
ANM analysis is a coarse-grained normal mode analysis, which models the structure as an elastic 
network with individual nodes corresponding to the α-carbons of the protein. Inter-residue 
interactions are described by harmonic potentials with uniform spring constant γ. For a protein of 
 135 
N residues, ANM predicts an ensemble of 3N-6 modes of motion. The motion along mode k 
changes the position of residue i as 
Ri(k)(±s) = Ri0 ± s λk(-½) [uk]i             (1) 
where Ri0 is the position vector in the original (i.e., X-ray) structure, s is a parameter that scales 
the size of the deformation induced by mode k, [uk]i is the ith super element (3-dimensional 
vector) of the kth eigenvector uk (a 3N-dimensional normalized vector) of the 3N × 3N Hessian 
matrix H, and λk is the corresponding eigenvalue (3-4). [uk]i  describes the motion of residue i 
along the kth principal/normal coordinate, and λk(-½) scales with the frequency of the kth mode, 
such that lower frequency modes make larger contributions to Ri(k). The lowest frequency modes, 
also called the softest modes, define the mechanisms of global reconfiguration intrinsically 
favored by the molecular architecture under physiological conditions. Here we carried out the 
ANM with default parameters based on the Gltph outward-facing structure (PDB ID: 1XFH), 
inward-facing structure (PDB ID: 3KBC), and models constructed for intermediate states (see 
below). 
6.16 MODELING THE STRUCTURE AND DYNAMICS OF INTERMEDIATE 
STATES 
Intermediate structures are constructed by assembling the individual inward-facing or outward-
facing subunits upon superimposition of their trimerization domains. The difference between any 
pair of structures (including the experimentally observed all-outward or all-inward states, and the 
modeled/assembled intermediate states) is quantitatively described by a 3N-dimensional 
deformation vector d, evaluated by overlaying the two structures to remove rigid-body 
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translations and rotations. The correlation between the kth mode of motion predicted by the ANM 
and the deformation d is given by cos(uk, d) = uk . d/|d| where |d| is the magnitude of d, and uk is 
the kth eigenvector calculated for the starting structure. The cumulative overlap between a subset 
of soft modes (m of them) and the observed/modeled structural change d is given by  
Ocum(m) = [∑ 𝑐𝑐𝑐𝑐𝑠𝑠2(𝒖𝒖𝑘𝑘 ,𝒅𝒅)𝑚𝑚𝑘𝑘=1 ]1/2    (2) 
By definition, Ocum(m) sums up to unity for m = 3N-6, because the 3N-6 eigenvectors form an 
orthonormal basis set that spans the space of conformational changes. In the extreme case of 
completely random modes, which are uncorrelated with d, Ocum(m) = (m/3N-6)1/2. This 
relationship defines the control curves in panels C and D of Figure 6. High cumulative overlaps 
achieved by a small subset of low frequency modes indicate the accessibility of the structural 
changes via soft (energetically favorable) motions.   
6.17 DATA ANALYSES 
All experiments reported were repeated a minimum of three times with similar results. Data were 
presented as mean ± SEM and were analyzed using student’s t-test or one-way ANOVA 
followed by Bonferroni’s multiple comparisons test using the software package Prism 4.0 
(Graphpad software). p<0.05 was considered to be statistically significant.  
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